{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "\n",
    "pd.set_option('display.max_columns', None)\n",
    "pd.set_option('display.max_rows', None)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\u001b[34mNotebooks\u001b[m\u001b[m/       \u001b[34meb-flask\u001b[m\u001b[m/        \u001b[34msample\u001b[m\u001b[m/          sampled_csv.csv\r\n"
     ]
    }
   ],
   "source": [
    "ls"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [],
   "source": [
    "df = pd.read_csv('sampled_csv.csv')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Unnamed: 0</th>\n",
       "      <th>address</th>\n",
       "      <th>agency</th>\n",
       "      <th>brief_summary</th>\n",
       "      <th>brief_title</th>\n",
       "      <th>city</th>\n",
       "      <th>clinical_study</th>\n",
       "      <th>collaborator</th>\n",
       "      <th>completion_date</th>\n",
       "      <th>condition</th>\n",
       "      <th>condition_browse</th>\n",
       "      <th>country</th>\n",
       "      <th>criteria</th>\n",
       "      <th>detailed_description</th>\n",
       "      <th>eligibility</th>\n",
       "      <th>enrollment</th>\n",
       "      <th>facility</th>\n",
       "      <th>gender</th>\n",
       "      <th>has_expanded_access</th>\n",
       "      <th>intervention</th>\n",
       "      <th>intervention_name</th>\n",
       "      <th>intervention_type</th>\n",
       "      <th>keyword</th>\n",
       "      <th>last_known_status</th>\n",
       "      <th>last_update_posted</th>\n",
       "      <th>last_update_submitted</th>\n",
       "      <th>last_update_submitted_qc</th>\n",
       "      <th>lead_sponsor</th>\n",
       "      <th>location</th>\n",
       "      <th>mesh_term</th>\n",
       "      <th>official_title</th>\n",
       "      <th>overall_status</th>\n",
       "      <th>phase</th>\n",
       "      <th>primary_completion_date</th>\n",
       "      <th>primary_purpose</th>\n",
       "      <th>role</th>\n",
       "      <th>source</th>\n",
       "      <th>sponsors</th>\n",
       "      <th>start_date</th>\n",
       "      <th>state</th>\n",
       "      <th>textblock</th>\n",
       "      <th>time_frame</th>\n",
       "      <th>time_perspective</th>\n",
       "      <th>url</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>University of Utah</td>\n",
       "      <td>\\n\\n      The purpose of this prospective tria...</td>\n",
       "      <td>Cancer Symptom Monitoring Telephone System Wit...</td>\n",
       "      <td>Nashville</td>\n",
       "      <td>\\n\\n\\nClinicalTrials.gov processed this data o...</td>\n",
       "      <td>\\nNational Cancer Institute (NCI)\\nNIH\\n</td>\n",
       "      <td>April 2012</td>\n",
       "      <td>Cancer</td>\n",
       "      <td>NaN</td>\n",
       "      <td>United States</td>\n",
       "      <td>\\n\\n        Inclusion Criteria:\\n\\n          -...</td>\n",
       "      <td>\\n\\n      The purpose of this prospective tria...</td>\n",
       "      <td>\\n\\n\\n        Inclusion Criteria:\\n\\n         ...</td>\n",
       "      <td>358.0</td>\n",
       "      <td>\\nVanderbilt-Ingram Cancer Center\\n\\nNashville...</td>\n",
       "      <td>All</td>\n",
       "      <td>No</td>\n",
       "      <td>\\nOther\\nSymptom Alert and Coaching\\nPatients ...</td>\n",
       "      <td>Symptom Alert and Coaching</td>\n",
       "      <td>Other</td>\n",
       "      <td>Cancer</td>\n",
       "      <td>NaN</td>\n",
       "      <td>March 1, 2017</td>\n",
       "      <td>February 28, 2017</td>\n",
       "      <td>February 28, 2017</td>\n",
       "      <td>\\nUniversity of Utah\\nOther\\n</td>\n",
       "      <td>\\n\\nVanderbilt-Ingram Cancer Center\\n\\nNashvil...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Telephone Linked Care: An IT Enabled Integrate...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>NaN</td>\n",
       "      <td>April 2012</td>\n",
       "      <td>Supportive Care</td>\n",
       "      <td>Principal Investigator</td>\n",
       "      <td>University of Utah</td>\n",
       "      <td>\\n\\nUniversity of Utah\\nOther\\n\\n\\nNational Ca...</td>\n",
       "      <td>September 2007</td>\n",
       "      <td>Tennessee</td>\n",
       "      <td>\\n      The purpose of this prospective trial ...</td>\n",
       "      <td>Daily patient reports of symptom levels were m...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>https://clinicaltrials.gov/show/NCT01973946</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Neurogen Brain and Spine Institute</td>\n",
       "      <td>\\n\\n      The purpose of this study was to stu...</td>\n",
       "      <td>Stem Cell Therapy in Autism Spectrum Disorders</td>\n",
       "      <td>Mumbai</td>\n",
       "      <td>\\n\\n\\nClinicalTrials.gov processed this data o...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>May 2016</td>\n",
       "      <td>Autism Spectrum Disorders</td>\n",
       "      <td>\\n\\nDisease\\nAutistic Disorder\\nAutism Spectru...</td>\n",
       "      <td>India</td>\n",
       "      <td>\\n\\n        Inclusion Criteria:\\n\\n          -...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>\\n\\n\\n        Inclusion Criteria:\\n\\n         ...</td>\n",
       "      <td>0.0</td>\n",
       "      <td>\\nNeurogen brain and spine institute\\n\\nMumbai...</td>\n",
       "      <td>All</td>\n",
       "      <td>No</td>\n",
       "      <td>\\nProcedure\\nAutologous bone marrow mononuclea...</td>\n",
       "      <td>Autologous bone marrow mononuclear cell transp...</td>\n",
       "      <td>Procedure</td>\n",
       "      <td>autism spectrum disorders</td>\n",
       "      <td>NaN</td>\n",
       "      <td>October 25, 2018</td>\n",
       "      <td>October 23, 2018</td>\n",
       "      <td>October 23, 2018</td>\n",
       "      <td>\\nNeurogen Brain and Spine Institute\\nOther\\n</td>\n",
       "      <td>\\n\\nNeurogen brain and spine institute\\n\\nMumb...</td>\n",
       "      <td>Disease</td>\n",
       "      <td>Open Label Study of Autologous Bone Marrow Mon...</td>\n",
       "      <td>Withdrawn</td>\n",
       "      <td>Phase 1</td>\n",
       "      <td>January 2016</td>\n",
       "      <td>Treatment</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Neurogen Brain and Spine Institute</td>\n",
       "      <td>\\n\\nNeurogen Brain and Spine Institute\\nOther\\n\\n</td>\n",
       "      <td>August 2009</td>\n",
       "      <td>Maharashtra</td>\n",
       "      <td>\\n      The purpose of this study was to study...</td>\n",
       "      <td>Six months</td>\n",
       "      <td>NaN</td>\n",
       "      <td>https://clinicaltrials.gov/show/NCT01974973</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Nektar Therapeutics</td>\n",
       "      <td>\\n\\n      The purpose of this research study i...</td>\n",
       "      <td>A Study in Cancer Patients to Evaluate the Eff...</td>\n",
       "      <td>Los Angeles</td>\n",
       "      <td>\\n\\n\\nClinicalTrials.gov processed this data o...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>September 2016</td>\n",
       "      <td>Advanced Cancer</td>\n",
       "      <td>NaN</td>\n",
       "      <td>United States</td>\n",
       "      <td>\\n\\n        Inclusion Criteria:\\n\\n          -...</td>\n",
       "      <td>\\n\\n      This is an open-label study that wil...</td>\n",
       "      <td>\\n\\n\\n        Inclusion Criteria:\\n\\n         ...</td>\n",
       "      <td>33.0</td>\n",
       "      <td>\\nAmerican Institute of Research, Los Angeles\\...</td>\n",
       "      <td>All</td>\n",
       "      <td>No</td>\n",
       "      <td>\\nDrug\\nNKTR-102\\nNKTR-102\\n</td>\n",
       "      <td>NKTR-102</td>\n",
       "      <td>Drug</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>December 22, 2016</td>\n",
       "      <td>December 20, 2016</td>\n",
       "      <td>December 20, 2016</td>\n",
       "      <td>\\nNektar Therapeutics\\nIndustry\\n</td>\n",
       "      <td>\\n\\nAmerican Institute of Research, Los Angele...</td>\n",
       "      <td>Etirinotecan pegol</td>\n",
       "      <td>A Phase 1 Study to Evaluate the Effect of Nktr...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Phase 1</td>\n",
       "      <td>June 2016</td>\n",
       "      <td>Treatment</td>\n",
       "      <td>Study Director</td>\n",
       "      <td>Nektar Therapeutics</td>\n",
       "      <td>\\n\\nNektar Therapeutics\\nIndustry\\n\\n</td>\n",
       "      <td>February 2014</td>\n",
       "      <td>California</td>\n",
       "      <td>\\n      The purpose of this research study is ...</td>\n",
       "      <td>Day -1 through Day 42</td>\n",
       "      <td>NaN</td>\n",
       "      <td>https://clinicaltrials.gov/show/NCT01976143</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>University of Oxford</td>\n",
       "      <td>\\n\\n      Pleural effusion is an extremely com...</td>\n",
       "      <td>Using Ultrasound to Predict the Results of Dra...</td>\n",
       "      <td>Oxford</td>\n",
       "      <td>\\n\\n\\nClinicalTrials.gov processed this data o...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>May 16, 2017</td>\n",
       "      <td>Pleural Effusion</td>\n",
       "      <td>\\n\\nPleural Effusion\\n</td>\n",
       "      <td>United Kingdom</td>\n",
       "      <td>\\n\\n        Inclusion Criteria:\\n\\n          -...</td>\n",
       "      <td>\\n\\n      Study-specific interventions will be...</td>\n",
       "      <td>\\n\\n\\n        Adults (&gt; or = 18 years old) und...</td>\n",
       "      <td>2.0</td>\n",
       "      <td>\\nChurchill Hospital\\n\\nOxford\\nOX3 7LE\\nUnite...</td>\n",
       "      <td>All</td>\n",
       "      <td>No</td>\n",
       "      <td>\\nOther\\nPleural Manometry\\nIntrapleural press...</td>\n",
       "      <td>Pleural Manometry</td>\n",
       "      <td>Other</td>\n",
       "      <td>Pleural Effusion</td>\n",
       "      <td>NaN</td>\n",
       "      <td>January 10, 2018</td>\n",
       "      <td>January 8, 2018</td>\n",
       "      <td>January 8, 2018</td>\n",
       "      <td>\\nUniversity of Oxford\\nOther\\n</td>\n",
       "      <td>\\n\\nChurchill Hospital\\n\\nOxford\\nOX3 7LE\\nUni...</td>\n",
       "      <td>Pleural Effusion</td>\n",
       "      <td>Correlation of Pleural Manometry With Real-tim...</td>\n",
       "      <td>Terminated</td>\n",
       "      <td>NaN</td>\n",
       "      <td>May 16, 2017</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Study Chair</td>\n",
       "      <td>University of Oxford</td>\n",
       "      <td>\\n\\nUniversity of Oxford\\nOther\\n\\n</td>\n",
       "      <td>August 1, 2014</td>\n",
       "      <td>NaN</td>\n",
       "      <td>\\n      Pleural effusion is an extremely commo...</td>\n",
       "      <td>Up to 3 months</td>\n",
       "      <td>Prospective</td>\n",
       "      <td>https://clinicaltrials.gov/show/NCT01973985</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>M.D. Anderson Cancer Center</td>\n",
       "      <td>\\n\\n      The goal of this clinical research s...</td>\n",
       "      <td>Widespread vs. Selective Screening for Hepatit...</td>\n",
       "      <td>Houston</td>\n",
       "      <td>\\n\\n\\nClinicalTrials.gov processed this data o...</td>\n",
       "      <td>\\nNational Cancer Institute (NCI)\\nNIH\\n</td>\n",
       "      <td>December 2019</td>\n",
       "      <td>Cancer</td>\n",
       "      <td>\\n\\nInfection\\nHepatitis\\nHepatitis A\\nHepatit...</td>\n",
       "      <td>United States</td>\n",
       "      <td>\\n\\n        Inclusion Criteria:\\n\\n          1...</td>\n",
       "      <td>\\n\\n      Enrollment Visit:\\n\\n      If you ag...</td>\n",
       "      <td>\\n\\n\\n        Adult cancer patients scheduled ...</td>\n",
       "      <td>3441.0</td>\n",
       "      <td>\\nUniversity of Texas MD Anderson Cancer Cente...</td>\n",
       "      <td>All</td>\n",
       "      <td>No</td>\n",
       "      <td>\\nOther\\nHBV screening tests\\nThree (3) hepati...</td>\n",
       "      <td>HBV screening tests</td>\n",
       "      <td>Other</td>\n",
       "      <td>hepatitis B virus infection</td>\n",
       "      <td>NaN</td>\n",
       "      <td>January 15, 2019</td>\n",
       "      <td>January 11, 2019</td>\n",
       "      <td>January 11, 2019</td>\n",
       "      <td>\\nM.D. Anderson Cancer Center\\nOther\\n</td>\n",
       "      <td>\\n\\nUniversity of Texas MD Anderson Cancer Cen...</td>\n",
       "      <td>Infection</td>\n",
       "      <td>Widespread Versus Selective Screening for Hepa...</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>NaN</td>\n",
       "      <td>December 2019</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Study Chair</td>\n",
       "      <td>M.D. Anderson Cancer Center</td>\n",
       "      <td>\\n\\nM.D. Anderson Cancer Center\\nOther\\n\\n\\nNa...</td>\n",
       "      <td>June 2013</td>\n",
       "      <td>Texas</td>\n",
       "      <td>\\n      The goal of this clinical research stu...</td>\n",
       "      <td>Baseline blood tests, approximately 30 minutes...</td>\n",
       "      <td>Prospective</td>\n",
       "      <td>https://clinicaltrials.gov/show/NCT01970254</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Erasmus Medical Center</td>\n",
       "      <td>\\n\\n      A prospective, randomised, controlle...</td>\n",
       "      <td>High Tibial Osteotomy for Osteoarthritis of th...</td>\n",
       "      <td>Rotterdam</td>\n",
       "      <td>\\n\\n\\nClinicalTrials.gov processed this data o...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>April 2004</td>\n",
       "      <td>Osteoarthritis</td>\n",
       "      <td>\\n\\nOsteoarthritis\\nOsteoarthritis, Knee\\n</td>\n",
       "      <td>Netherlands</td>\n",
       "      <td>\\n\\n        Inclusion Criteria:\\n\\n          -...</td>\n",
       "      <td>\\n\\n      A prospective, randomised, controlle...</td>\n",
       "      <td>\\n\\n\\n        Inclusion Criteria:\\n\\n         ...</td>\n",
       "      <td>92.0</td>\n",
       "      <td>\\nErasmus Medical Centre\\n\\nRotterdam\\n3015 CE...</td>\n",
       "      <td>All</td>\n",
       "      <td>No</td>\n",
       "      <td>\\nProcedure\\nOpening-wedge HTO\\nOpening-wedge ...</td>\n",
       "      <td>Opening-wedge HTO</td>\n",
       "      <td>Procedure</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>November 6, 2013</td>\n",
       "      <td>October 30, 2013</td>\n",
       "      <td>October 30, 2013</td>\n",
       "      <td>\\nErasmus Medical Center\\nOther\\n</td>\n",
       "      <td>\\n\\nErasmus Medical Centre\\n\\nRotterdam\\n3015 ...</td>\n",
       "      <td>Osteoarthritis</td>\n",
       "      <td>High Tibial Osteotomy for Osteoarthritis of th...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>NaN</td>\n",
       "      <td>April 2004</td>\n",
       "      <td>Treatment</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Erasmus Medical Center</td>\n",
       "      <td>\\n\\nErasmus Medical Center\\nOther\\n\\n</td>\n",
       "      <td>January 2001</td>\n",
       "      <td>NaN</td>\n",
       "      <td>\\n      A prospective, randomised, controlled ...</td>\n",
       "      <td>one year</td>\n",
       "      <td>NaN</td>\n",
       "      <td>https://clinicaltrials.gov/show/NCT01977261</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Medical University of Vienna</td>\n",
       "      <td>\\n\\n      Dry eye syndrome (DES) is a common o...</td>\n",
       "      <td>Effect of Olixia Pure速 Eye Drops on Tear Film ...</td>\n",
       "      <td>Vienna</td>\n",
       "      <td>\\n\\n\\nClinicalTrials.gov processed this data o...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>November 2013</td>\n",
       "      <td>Dry Eye Syndrome</td>\n",
       "      <td>\\n\\nDry Eye Syndromes\\nKeratoconjunctivitis Si...</td>\n",
       "      <td>Austria</td>\n",
       "      <td>\\n\\n        Inclusion Criteria:\\n\\n          -...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>\\n\\n\\n        Inclusion Criteria:\\n\\n         ...</td>\n",
       "      <td>16.0</td>\n",
       "      <td>\\nDepartment of Clinical Pharmacology\\n\\nVienn...</td>\n",
       "      <td>All</td>\n",
       "      <td>No</td>\n",
       "      <td>\\nDevice\\nOlixia pure eye drops\\nHealthy volun...</td>\n",
       "      <td>Olixia pure eye drops</td>\n",
       "      <td>Device</td>\n",
       "      <td>tear film thickness</td>\n",
       "      <td>NaN</td>\n",
       "      <td>November 27, 2013</td>\n",
       "      <td>November 26, 2013</td>\n",
       "      <td>November 26, 2013</td>\n",
       "      <td>\\nMedical University of Vienna\\nOther\\n</td>\n",
       "      <td>\\n\\nDepartment of Clinical Pharmacology\\n\\nVie...</td>\n",
       "      <td>Dry Eye Syndromes</td>\n",
       "      <td>Effect of Olixia Pure速 Eye Drops on Tear Film ...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Phase 4</td>\n",
       "      <td>November 2013</td>\n",
       "      <td>Basic Science</td>\n",
       "      <td>Principal Investigator</td>\n",
       "      <td>Medical University of Vienna</td>\n",
       "      <td>\\n\\nMedical University of Vienna\\nOther\\n\\n</td>\n",
       "      <td>October 2013</td>\n",
       "      <td>NaN</td>\n",
       "      <td>\\n      Dry eye syndrome (DES) is a common ocu...</td>\n",
       "      <td>up to one hour</td>\n",
       "      <td>NaN</td>\n",
       "      <td>https://clinicaltrials.gov/show/NCT01970917</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Novartis</td>\n",
       "      <td>\\n\\n      The purpose of the study is to evalu...</td>\n",
       "      <td>Efficacy and Safety of Acetaminophen and Aspir...</td>\n",
       "      <td>Birmingham</td>\n",
       "      <td>\\n\\n\\nClinicalTrials.gov processed this data o...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>July 2014</td>\n",
       "      <td>Acute Migraine</td>\n",
       "      <td>\\n\\nMigraine Disorders\\n</td>\n",
       "      <td>United States</td>\n",
       "      <td>\\n\\n        Inclusion criteria:\\n\\n          1...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>\\n\\n\\n        Inclusion criteria:\\n\\n         ...</td>\n",
       "      <td>900.0</td>\n",
       "      <td>\\n\\nBirmingham\\nAlabama\\nUnited States\\n\\n</td>\n",
       "      <td>All</td>\n",
       "      <td>No</td>\n",
       "      <td>\\nDrug\\nAcetaminophen 250 mg and Aspirin 250 m...</td>\n",
       "      <td>Acetaminophen 250 mg and Aspirin 250 mg</td>\n",
       "      <td>Drug</td>\n",
       "      <td>Migraine</td>\n",
       "      <td>NaN</td>\n",
       "      <td>June 11, 2015</td>\n",
       "      <td>June 9, 2015</td>\n",
       "      <td>June 9, 2015</td>\n",
       "      <td>\\nNovartis\\nIndustry\\n</td>\n",
       "      <td>\\n\\n\\nBirmingham\\nAlabama\\nUnited States\\n\\n\\n</td>\n",
       "      <td>Migraine Disorders</td>\n",
       "      <td>A Multi-center, Randomized, Double-blind, Para...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>July 2014</td>\n",
       "      <td>Treatment</td>\n",
       "      <td>Study Director</td>\n",
       "      <td>Novartis</td>\n",
       "      <td>\\n\\nNovartis\\nIndustry\\n\\n</td>\n",
       "      <td>October 2013</td>\n",
       "      <td>Alabama</td>\n",
       "      <td>\\n      The purpose of the study is to evaluat...</td>\n",
       "      <td>2 hours</td>\n",
       "      <td>NaN</td>\n",
       "      <td>https://clinicaltrials.gov/show/NCT01973205</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Chengdu University of Traditional Chinese Medi...</td>\n",
       "      <td>\\n\\n      Hypothesis: Moxibustion is effective...</td>\n",
       "      <td>Moxibustion for Primary Dysmenorrhea</td>\n",
       "      <td>Chengdu</td>\n",
       "      <td>\\n\\n\\nClinicalTrials.gov processed this data o...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>June 2014</td>\n",
       "      <td>Primary Dysmenorrhea</td>\n",
       "      <td>\\n\\nDysmenorrhea\\n</td>\n",
       "      <td>China</td>\n",
       "      <td>\\n\\n        Inclusion Criteria:\\n\\n          -...</td>\n",
       "      <td>\\n\\n      There is no convincing evidence for ...</td>\n",
       "      <td>\\n\\n\\n        Inclusion Criteria:\\n\\n         ...</td>\n",
       "      <td>152.0</td>\n",
       "      <td>\\nAffiliated hospital of Chengdu University of...</td>\n",
       "      <td>Female</td>\n",
       "      <td>No</td>\n",
       "      <td>\\nDevice\\nmoxibustion\\napply moxibustion accor...</td>\n",
       "      <td>moxibustion</td>\n",
       "      <td>Device</td>\n",
       "      <td>moxibustion</td>\n",
       "      <td>NaN</td>\n",
       "      <td>December 2, 2014</td>\n",
       "      <td>November 25, 2014</td>\n",
       "      <td>November 25, 2014</td>\n",
       "      <td>\\nChengdu University of Traditional Chinese Me...</td>\n",
       "      <td>\\n\\nAffiliated hospital of Chengdu University ...</td>\n",
       "      <td>Dysmenorrhea</td>\n",
       "      <td>Traditional Chinese Moxibustion for Primary Dy...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Early Phase 1</td>\n",
       "      <td>February 2014</td>\n",
       "      <td>Treatment</td>\n",
       "      <td>Principal Investigator</td>\n",
       "      <td>Chengdu University of Traditional Chinese Medi...</td>\n",
       "      <td>\\n\\nChengdu University of Traditional Chinese ...</td>\n",
       "      <td>February 2012</td>\n",
       "      <td>Sichuan</td>\n",
       "      <td>\\n      Hypothesis: Moxibustion is effective f...</td>\n",
       "      <td>at baseline, 1st, 2nd, 3rd, 4th, 5th, 6th mens...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>https://clinicaltrials.gov/show/NCT01972906</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>University of Bergen</td>\n",
       "      <td>\\n\\n      The primary outcome in this study is...</td>\n",
       "      <td>Priority Setting and Waiting Time Decision in ...</td>\n",
       "      <td>Stavanger</td>\n",
       "      <td>\\n\\n\\nClinicalTrials.gov processed this data o...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>June 2014</td>\n",
       "      <td>Communication</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Norway</td>\n",
       "      <td>\\n\\n        Inclusion Criteria:\\n\\n        All...</td>\n",
       "      <td>\\n\\n      Design:\\n\\n      A prospective clust...</td>\n",
       "      <td>\\n\\n\\n        Inclusion Criteria:\\n\\n        A...</td>\n",
       "      <td>40.0</td>\n",
       "      <td>\\nStavanger University Hospital\\n\\nStavanger\\n...</td>\n",
       "      <td>All</td>\n",
       "      <td>No</td>\n",
       "      <td>\\nBehavioral\\nPrioritization\\nteam-based multi...</td>\n",
       "      <td>Prioritization</td>\n",
       "      <td>Behavioral</td>\n",
       "      <td>Comprehensive referrals</td>\n",
       "      <td>Not yet recruiting</td>\n",
       "      <td>November 5, 2013</td>\n",
       "      <td>October 29, 2013</td>\n",
       "      <td>October 29, 2013</td>\n",
       "      <td>\\nUniversity of Bergen\\nOther\\n</td>\n",
       "      <td>\\n\\nStavanger University Hospital\\n\\nStavanger...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Priority Setting and Waiting Time Decision in ...</td>\n",
       "      <td>Unknown status</td>\n",
       "      <td>NaN</td>\n",
       "      <td>June 2014</td>\n",
       "      <td>Health Services Research</td>\n",
       "      <td>Study Chair</td>\n",
       "      <td>University of Bergen</td>\n",
       "      <td>\\n\\nUniversity of Bergen\\nOther\\n\\n</td>\n",
       "      <td>January 2014</td>\n",
       "      <td>NaN</td>\n",
       "      <td>\\n      The primary outcome in this study is m...</td>\n",
       "      <td>1 year</td>\n",
       "      <td>NaN</td>\n",
       "      <td>https://clinicaltrials.gov/show/NCT01976221</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>CancerCare Manitoba</td>\n",
       "      <td>\\n\\n      Cancer which spreads to the brain (b...</td>\n",
       "      <td>Neurocognition After Gamma Knife Radiosurgery ...</td>\n",
       "      <td>Winnipeg</td>\n",
       "      <td>\\n\\n\\nClinicalTrials.gov processed this data o...</td>\n",
       "      <td>\\nHealth Sciences Centre Foundation, Manitoba\\...</td>\n",
       "      <td>September 2015</td>\n",
       "      <td>Neoplasm Metastases</td>\n",
       "      <td>\\n\\nNeoplasms\\nNeoplasm Metastasis\\nNeoplasms,...</td>\n",
       "      <td>Canada</td>\n",
       "      <td>\\n\\n        Inclusion Criteria:\\n\\n          -...</td>\n",
       "      <td>\\n\\n      Patients with &gt;=4 brain metastases w...</td>\n",
       "      <td>\\n\\n\\n        Patients with multiple (&gt;= 4) br...</td>\n",
       "      <td>3.0</td>\n",
       "      <td>\\nHealth Sciences Centre / CancerCare Manitoba...</td>\n",
       "      <td>All</td>\n",
       "      <td>No</td>\n",
       "      <td>\\nRadiation\\nGamma knife radiosurgery\\nDependi...</td>\n",
       "      <td>Gamma knife radiosurgery</td>\n",
       "      <td>Radiation</td>\n",
       "      <td>Neoplasm metastasis</td>\n",
       "      <td>NaN</td>\n",
       "      <td>May 30, 2016</td>\n",
       "      <td>May 27, 2016</td>\n",
       "      <td>May 27, 2016</td>\n",
       "      <td>\\nCancerCare Manitoba\\nOther\\n</td>\n",
       "      <td>\\n\\nHealth Sciences Centre / CancerCare Manito...</td>\n",
       "      <td>Neoplasms</td>\n",
       "      <td>Neurocognition After Gamma Knife Radiosurgery ...</td>\n",
       "      <td>Terminated</td>\n",
       "      <td>NaN</td>\n",
       "      <td>September 2015</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Principal Investigator</td>\n",
       "      <td>CancerCare Manitoba</td>\n",
       "      <td>\\n\\nCancerCare Manitoba\\nOther\\n\\n\\nHealth Sci...</td>\n",
       "      <td>April 2014</td>\n",
       "      <td>Manitoba</td>\n",
       "      <td>\\n      Cancer which spreads to the brain (bra...</td>\n",
       "      <td>4 months after radiosurgery</td>\n",
       "      <td>Prospective</td>\n",
       "      <td>https://clinicaltrials.gov/show/NCT01970644</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Association for Innovation and Biomedical Rese...</td>\n",
       "      <td>\\n\\n      Bimatoprost 0.03% preservative free ...</td>\n",
       "      <td>Intraocular Pressure and Tolerability Study of...</td>\n",
       "      <td>Vienna</td>\n",
       "      <td>\\n\\n\\nClinicalTrials.gov processed this data o...</td>\n",
       "      <td>\\nEuropean Vision Institute Clinical Research ...</td>\n",
       "      <td>February 2015</td>\n",
       "      <td>Glaucoma</td>\n",
       "      <td>\\n\\nHypertension\\nGlaucoma\\nOcular Hypertension\\n</td>\n",
       "      <td>Austria</td>\n",
       "      <td>\\n\\n        Inclusion Criteria includes:\\n\\n  ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>\\n\\n\\n        Inclusion Criteria includes:\\n\\n...</td>\n",
       "      <td>67.0</td>\n",
       "      <td>\\n\\nVienna\\nAustria\\n\\n</td>\n",
       "      <td>All</td>\n",
       "      <td>No</td>\n",
       "      <td>\\nDrug\\nPreservative-free latanoprost\\nLatanop...</td>\n",
       "      <td>Preservative-free latanoprost</td>\n",
       "      <td>Drug</td>\n",
       "      <td>Glaucoma</td>\n",
       "      <td>NaN</td>\n",
       "      <td>October 29, 2015</td>\n",
       "      <td>October 28, 2015</td>\n",
       "      <td>October 28, 2015</td>\n",
       "      <td>\\nAssociation for Innovation and Biomedical Re...</td>\n",
       "      <td>\\n\\n\\nVienna\\nAustria\\n\\n\\n</td>\n",
       "      <td>Hypertension</td>\n",
       "      <td>Intraocular Pressure and Tolerability Study of...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Phase 4</td>\n",
       "      <td>February 2015</td>\n",
       "      <td>Treatment</td>\n",
       "      <td>Principal Investigator</td>\n",
       "      <td>Association for Innovation and Biomedical Rese...</td>\n",
       "      <td>\\n\\nAssociation for Innovation and Biomedical ...</td>\n",
       "      <td>October 2013</td>\n",
       "      <td>NaN</td>\n",
       "      <td>\\n      Bimatoprost 0.03% preservative free mo...</td>\n",
       "      <td>6 months</td>\n",
       "      <td>NaN</td>\n",
       "      <td>https://clinicaltrials.gov/show/NCT01975714</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>University of Nebraska</td>\n",
       "      <td>\\n\\n      Sjogren-Larsson syndrome (SLS) is a ...</td>\n",
       "      <td>Sjogren-Larsson Syndrome: Natural History, Cli...</td>\n",
       "      <td>Omaha</td>\n",
       "      <td>\\n\\n\\nClinicalTrials.gov processed this data o...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>August 2019</td>\n",
       "      <td>Sjogren-Larsson Syndrome (SLS)</td>\n",
       "      <td>\\n\\nSyndrome\\nSjogren's Syndrome\\nSjogren-Lars...</td>\n",
       "      <td>United States</td>\n",
       "      <td>\\n\\n        Inclusion Criteria:\\n\\n          -...</td>\n",
       "      <td>\\n\\n      The study will consist of a clinical...</td>\n",
       "      <td>\\n\\n\\n        The study population will come f...</td>\n",
       "      <td>50.0</td>\n",
       "      <td>\\nUniversity of Nebraska Medical Center\\n\\nOma...</td>\n",
       "      <td>All</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ichthyosis</td>\n",
       "      <td>NaN</td>\n",
       "      <td>March 11, 2019</td>\n",
       "      <td>March 8, 2019</td>\n",
       "      <td>March 8, 2019</td>\n",
       "      <td>\\nUniversity of Nebraska\\nOther\\n</td>\n",
       "      <td>\\n\\nUniversity of Nebraska Medical Center\\n\\nO...</td>\n",
       "      <td>Syndrome</td>\n",
       "      <td>Sjogren-Larsson Syndrome: A Longitudinal Study...</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>NaN</td>\n",
       "      <td>August 2019</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Study Chair</td>\n",
       "      <td>University of Nebraska</td>\n",
       "      <td>\\n\\nUniversity of Nebraska\\nOther\\n\\n</td>\n",
       "      <td>April 2013</td>\n",
       "      <td>Nebraska</td>\n",
       "      <td>\\n      Sjogren-Larsson syndrome (SLS) is a ra...</td>\n",
       "      <td>2017 (up to 5 years)</td>\n",
       "      <td>Prospective</td>\n",
       "      <td>https://clinicaltrials.gov/show/NCT01971957</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>CancerCare Manitoba</td>\n",
       "      <td>\\n\\n      To improve radiation therapy of pros...</td>\n",
       "      <td>Functional MR-guided Stereotactic Body Radiati...</td>\n",
       "      <td>Winnipeg</td>\n",
       "      <td>\\n\\n\\nClinicalTrials.gov processed this data o...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>December 2022</td>\n",
       "      <td>Prostatic Neoplasms</td>\n",
       "      <td>\\n\\nProstatic Neoplasms\\n</td>\n",
       "      <td>Canada</td>\n",
       "      <td>\\n\\n        Inclusion Criteria:\\n\\n          -...</td>\n",
       "      <td>\\n\\n      This project combines advances in fu...</td>\n",
       "      <td>\\n\\n\\n        Inclusion Criteria:\\n\\n         ...</td>\n",
       "      <td>77.0</td>\n",
       "      <td>\\nCancerCare Manitoba\\n\\nWinnipeg\\nManitoba\\nR...</td>\n",
       "      <td>Male</td>\n",
       "      <td>No</td>\n",
       "      <td>\\nRadiation\\nStereotactic body RT with MR-guid...</td>\n",
       "      <td>Stereotactic body RT with MR-guided boost</td>\n",
       "      <td>Radiation</td>\n",
       "      <td>Prostatic neoplasms</td>\n",
       "      <td>NaN</td>\n",
       "      <td>February 20, 2019</td>\n",
       "      <td>February 19, 2019</td>\n",
       "      <td>February 19, 2019</td>\n",
       "      <td>\\nCancerCare Manitoba\\nOther\\n</td>\n",
       "      <td>\\n\\nCancerCare Manitoba\\n\\nWinnipeg\\nManitoba\\...</td>\n",
       "      <td>Prostatic Neoplasms</td>\n",
       "      <td>Functional MR-guided Stereotactic Body Radiati...</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>NaN</td>\n",
       "      <td>December 2020</td>\n",
       "      <td>Treatment</td>\n",
       "      <td>Principal Investigator</td>\n",
       "      <td>CancerCare Manitoba</td>\n",
       "      <td>\\n\\nCancerCare Manitoba\\nOther\\n\\n</td>\n",
       "      <td>January 10, 2018</td>\n",
       "      <td>Manitoba</td>\n",
       "      <td>\\n      To improve radiation therapy of prosta...</td>\n",
       "      <td>6 months</td>\n",
       "      <td>NaN</td>\n",
       "      <td>https://clinicaltrials.gov/show/NCT01976962</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Cutera Inc.</td>\n",
       "      <td>\\n\\n      The purpose of this study is to comp...</td>\n",
       "      <td>Study of Picosecond and Nanosecond Q-switched ...</td>\n",
       "      <td>Brisbane</td>\n",
       "      <td>\\n\\n\\nClinicalTrials.gov processed this data o...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Tattoo Removal</td>\n",
       "      <td>NaN</td>\n",
       "      <td>United States</td>\n",
       "      <td>\\n\\n        Inclusion Criteria:\\n\\n          -...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>\\n\\n\\n        Inclusion Criteria:\\n\\n         ...</td>\n",
       "      <td>44.0</td>\n",
       "      <td>\\n\\nBrisbane\\nCalifornia\\nUnited States\\n\\n</td>\n",
       "      <td>All</td>\n",
       "      <td>No</td>\n",
       "      <td>\\nDevice\\nPicosecond Q-switched Laser Treatmen...</td>\n",
       "      <td>Picosecond Q-switched Laser Treatment</td>\n",
       "      <td>Device</td>\n",
       "      <td>Tattoo Removal</td>\n",
       "      <td>NaN</td>\n",
       "      <td>July 28, 2014</td>\n",
       "      <td>July 24, 2014</td>\n",
       "      <td>July 24, 2014</td>\n",
       "      <td>\\nCutera Inc.\\nIndustry\\n</td>\n",
       "      <td>\\n\\n\\nBrisbane\\nCalifornia\\nUnited States\\n\\n\\n</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Randomized, Split-tattoo Study Comparing Safet...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>NaN</td>\n",
       "      <td>July 2014</td>\n",
       "      <td>Treatment</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Cutera Inc.</td>\n",
       "      <td>\\n\\nCutera Inc.\\nIndustry\\n\\n</td>\n",
       "      <td>September 2013</td>\n",
       "      <td>California</td>\n",
       "      <td>\\n      The purpose of this study is to compar...</td>\n",
       "      <td>12-weeks post-final laser treatment</td>\n",
       "      <td>NaN</td>\n",
       "      <td>https://clinicaltrials.gov/show/NCT01973166</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Horizon Health Network</td>\n",
       "      <td>\\n\\n      The purposes of this noninferiority ...</td>\n",
       "      <td>Narcotic vs. Non-narcotic Pain Study Protocol</td>\n",
       "      <td>Philadelphia</td>\n",
       "      <td>\\n\\n\\nClinicalTrials.gov processed this data o...</td>\n",
       "      <td>\\nLawson Health Research Institute\\nOther\\n</td>\n",
       "      <td>March 2019</td>\n",
       "      <td>Carpal Tunnel</td>\n",
       "      <td>\\n\\nCarpal Tunnel Syndrome\\n</td>\n",
       "      <td>United States</td>\n",
       "      <td>\\n\\n        Inclusion Criteria:\\n\\n          -...</td>\n",
       "      <td>\\n\\n      Participants will be provided with f...</td>\n",
       "      <td>\\n\\n\\n        Inclusion Criteria:\\n\\n         ...</td>\n",
       "      <td>400.0</td>\n",
       "      <td>\\nThe Philadelphia Hand Center\\n\\nPhiladelphia...</td>\n",
       "      <td>All</td>\n",
       "      <td>No</td>\n",
       "      <td>\\nDrug\\nNarcotic\\nHydrocodone 5mg + acetaminop...</td>\n",
       "      <td>Narcotic</td>\n",
       "      <td>Drug</td>\n",
       "      <td>pain relief</td>\n",
       "      <td>NaN</td>\n",
       "      <td>November 14, 2018</td>\n",
       "      <td>November 11, 2018</td>\n",
       "      <td>November 11, 2018</td>\n",
       "      <td>\\nHorizon Health Network\\nOther\\n</td>\n",
       "      <td>\\n\\nThe Philadelphia Hand Center\\n\\nPhiladelph...</td>\n",
       "      <td>Carpal Tunnel Syndrome</td>\n",
       "      <td>A Randomized, Controlled Trial Comparing Combi...</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Phase 4</td>\n",
       "      <td>March 2019</td>\n",
       "      <td>Supportive Care</td>\n",
       "      <td>Principal Investigator</td>\n",
       "      <td>Horizon Health Network</td>\n",
       "      <td>\\n\\nHorizon Health Network\\nOther\\n\\n\\nLawson ...</td>\n",
       "      <td>March 2016</td>\n",
       "      <td>Pennsylvania</td>\n",
       "      <td>\\n      The purposes of this noninferiority ra...</td>\n",
       "      <td>7-15 days</td>\n",
       "      <td>NaN</td>\n",
       "      <td>https://clinicaltrials.gov/show/NCT01974609</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>University of British Columbia</td>\n",
       "      <td>\\n\\n      Hypothesis: Continuation of an atypi...</td>\n",
       "      <td>Atypical Antipsychotics for Continuation and M...</td>\n",
       "      <td>Vancouver</td>\n",
       "      <td>\\n\\n\\nClinicalTrials.gov processed this data o...</td>\n",
       "      <td>\\nCanadian Institutes of Health Research (CIHR...</td>\n",
       "      <td>August 2011</td>\n",
       "      <td>Bipolar I Disorder</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Canada</td>\n",
       "      <td>\\n\\n        Inclusion Criteria:\\n\\n          -...</td>\n",
       "      <td>\\n\\n      This is a randomised, double-blind, ...</td>\n",
       "      <td>\\n\\n\\n        Inclusion Criteria:\\n\\n         ...</td>\n",
       "      <td>159.0</td>\n",
       "      <td>\\nUniversity of British Columbia\\n\\nVancouver\\...</td>\n",
       "      <td>All</td>\n",
       "      <td>No</td>\n",
       "      <td>\\nDrug\\nValproate\\nserum level of 50 to 125 ug...</td>\n",
       "      <td>Valproate</td>\n",
       "      <td>Drug</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>November 20, 2015</td>\n",
       "      <td>November 19, 2015</td>\n",
       "      <td>November 19, 2015</td>\n",
       "      <td>\\nUniversity of British Columbia\\nOther\\n</td>\n",
       "      <td>\\n\\nUniversity of British Columbia\\n\\nVancouve...</td>\n",
       "      <td>Risperidone</td>\n",
       "      <td>Atypical Antipsychotics for Continuation and M...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>August 2011</td>\n",
       "      <td>Treatment</td>\n",
       "      <td>Principal Investigator</td>\n",
       "      <td>University of British Columbia</td>\n",
       "      <td>\\n\\nUniversity of British Columbia\\nOther\\n\\n\\...</td>\n",
       "      <td>January 2003</td>\n",
       "      <td>British Columbia</td>\n",
       "      <td>\\n      Hypothesis: Continuation of an atypica...</td>\n",
       "      <td>52 weeks</td>\n",
       "      <td>NaN</td>\n",
       "      <td>https://clinicaltrials.gov/show/NCT01977300</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Cedars-Sinai Medical Center</td>\n",
       "      <td>\\n\\n      Patients undergoing major colorectal...</td>\n",
       "      <td>Prospective Study on Preoperative Versus Posto...</td>\n",
       "      <td>Los Angeles</td>\n",
       "      <td>\\n\\n\\nClinicalTrials.gov processed this data o...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>May 2015</td>\n",
       "      <td>Venous Thromboembolism</td>\n",
       "      <td>\\n\\nThromboembolism\\nVenous Thromboembolism\\n</td>\n",
       "      <td>United States</td>\n",
       "      <td>\\n\\n        Inclusion Criteria:\\n\\n          1...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>\\n\\n\\n        Inclusion Criteria:\\n\\n         ...</td>\n",
       "      <td>410.0</td>\n",
       "      <td>\\nCedars Sinai Medical Center\\n\\nLos Angeles\\n...</td>\n",
       "      <td>All</td>\n",
       "      <td>No</td>\n",
       "      <td>\\nDrug\\nHeparin\\nSubcutaneous Heparin 5000 Uni...</td>\n",
       "      <td>Heparin</td>\n",
       "      <td>Drug</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>October 14, 2016</td>\n",
       "      <td>August 21, 2016</td>\n",
       "      <td>August 21, 2016</td>\n",
       "      <td>\\nCedars-Sinai Medical Center\\nOther\\n</td>\n",
       "      <td>\\n\\nCedars Sinai Medical Center\\n\\nLos Angeles...</td>\n",
       "      <td>Thromboembolism</td>\n",
       "      <td>PROSPECTIVE STUDY ON PREOPERATIVE VERSUS POSTO...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>May 2015</td>\n",
       "      <td>Prevention</td>\n",
       "      <td>Principal Investigator</td>\n",
       "      <td>Cedars-Sinai Medical Center</td>\n",
       "      <td>\\n\\nCedars-Sinai Medical Center\\nOther\\n\\n</td>\n",
       "      <td>September 2013</td>\n",
       "      <td>California</td>\n",
       "      <td>\\n      Patients undergoing major colorectal s...</td>\n",
       "      <td>48 hour postop period</td>\n",
       "      <td>NaN</td>\n",
       "      <td>https://clinicaltrials.gov/show/NCT01976988</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Liverpool Heart and Chest Hospital NHS Foundat...</td>\n",
       "      <td>\\n\\n      Most Cystic fibrosis (CF) patients n...</td>\n",
       "      <td>Investigating the Incretin Effect in Cystic Fi...</td>\n",
       "      <td>Liverpool</td>\n",
       "      <td>\\n\\n\\nClinicalTrials.gov processed this data o...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>July 2015</td>\n",
       "      <td>Cystic Fibrosis</td>\n",
       "      <td>\\n\\nFibrosis\\nCystic Fibrosis\\n</td>\n",
       "      <td>United Kingdom</td>\n",
       "      <td>\\n\\n        Inclusion Criteria:\\n\\n          -...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>\\n\\n\\n        The CF Cohort will be recruited ...</td>\n",
       "      <td>50.0</td>\n",
       "      <td>\\nLiverpool Heart and Chest Hospital\\n\\nLiverp...</td>\n",
       "      <td>All</td>\n",
       "      <td>No</td>\n",
       "      <td>\\nDrug\\nOral Glucose Tolerance test (75g 2-hou...</td>\n",
       "      <td>Oral Glucose Tolerance test (75g 2-hour)</td>\n",
       "      <td>Drug</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>September 2, 2015</td>\n",
       "      <td>September 1, 2015</td>\n",
       "      <td>September 1, 2015</td>\n",
       "      <td>\\nLiverpool Heart and Chest Hospital NHS Found...</td>\n",
       "      <td>\\n\\nLiverpool Heart and Chest Hospital\\n\\nLive...</td>\n",
       "      <td>Fibrosis</td>\n",
       "      <td>Investigating the Incretin Effect in Cystic Fi...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>NaN</td>\n",
       "      <td>July 2015</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Principal Investigator</td>\n",
       "      <td>Liverpool Heart and Chest Hospital NHS Foundat...</td>\n",
       "      <td>\\n\\nLiverpool Heart and Chest Hospital NHS Fou...</td>\n",
       "      <td>December 2013</td>\n",
       "      <td>NaN</td>\n",
       "      <td>\\n      Most Cystic fibrosis (CF) patients now...</td>\n",
       "      <td>4 hours</td>\n",
       "      <td>Prospective</td>\n",
       "      <td>https://clinicaltrials.gov/show/NCT01975259</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Shaare Zedek Medical Center</td>\n",
       "      <td>\\n\\n      In the current study we will examine...</td>\n",
       "      <td>The Effect of Physical Effort in the Decision ...</td>\n",
       "      <td>Jerusalem</td>\n",
       "      <td>\\n\\n\\nClinicalTrials.gov processed this data o...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>April 2015</td>\n",
       "      <td>ADHD</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Israel</td>\n",
       "      <td>\\n\\n        Inclusion Criteria:\\n\\n          -...</td>\n",
       "      <td>\\n\\n      In the current study we will examine...</td>\n",
       "      <td>\\n\\n\\n        residents of jerusalem\\n      \\n...</td>\n",
       "      <td>60.0</td>\n",
       "      <td>\\nShaarei Zedek Medical Center\\n\\nJerusalem\\nI...</td>\n",
       "      <td>All</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>September 9, 2015</td>\n",
       "      <td>September 6, 2015</td>\n",
       "      <td>September 6, 2015</td>\n",
       "      <td>\\nShaare Zedek Medical Center\\nOther\\n</td>\n",
       "      <td>\\n\\nShaarei Zedek Medical Center\\n\\nJerusalem\\...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>The Effect of Physical Effort in the Decision ...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>NaN</td>\n",
       "      <td>April 2015</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Principal Investigator</td>\n",
       "      <td>Shaare Zedek Medical Center</td>\n",
       "      <td>\\n\\nShaare Zedek Medical Center\\nOther\\n\\n</td>\n",
       "      <td>November 2014</td>\n",
       "      <td>NaN</td>\n",
       "      <td>\\n      In the current study we will examine a...</td>\n",
       "      <td>immediately after testing</td>\n",
       "      <td>Cross-Sectional</td>\n",
       "      <td>https://clinicaltrials.gov/show/NCT01978769</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "    Unnamed: 0  address                                             agency  \\\n",
       "0            0      NaN                                 University of Utah   \n",
       "1            0      NaN                 Neurogen Brain and Spine Institute   \n",
       "2            0      NaN                                Nektar Therapeutics   \n",
       "3            0      NaN                               University of Oxford   \n",
       "4            0      NaN                        M.D. Anderson Cancer Center   \n",
       "5            0      NaN                             Erasmus Medical Center   \n",
       "6            0      NaN                       Medical University of Vienna   \n",
       "7            0      NaN                                           Novartis   \n",
       "8            0      NaN  Chengdu University of Traditional Chinese Medi...   \n",
       "9            0      NaN                               University of Bergen   \n",
       "10           0      NaN                                CancerCare Manitoba   \n",
       "11           0      NaN  Association for Innovation and Biomedical Rese...   \n",
       "12           0      NaN                             University of Nebraska   \n",
       "13           0      NaN                                CancerCare Manitoba   \n",
       "14           0      NaN                                        Cutera Inc.   \n",
       "15           0      NaN                             Horizon Health Network   \n",
       "16           0      NaN                     University of British Columbia   \n",
       "17           0      NaN                        Cedars-Sinai Medical Center   \n",
       "18           0      NaN  Liverpool Heart and Chest Hospital NHS Foundat...   \n",
       "19           0      NaN                        Shaare Zedek Medical Center   \n",
       "\n",
       "                                        brief_summary  \\\n",
       "0   \\n\\n      The purpose of this prospective tria...   \n",
       "1   \\n\\n      The purpose of this study was to stu...   \n",
       "2   \\n\\n      The purpose of this research study i...   \n",
       "3   \\n\\n      Pleural effusion is an extremely com...   \n",
       "4   \\n\\n      The goal of this clinical research s...   \n",
       "5   \\n\\n      A prospective, randomised, controlle...   \n",
       "6   \\n\\n      Dry eye syndrome (DES) is a common o...   \n",
       "7   \\n\\n      The purpose of the study is to evalu...   \n",
       "8   \\n\\n      Hypothesis: Moxibustion is effective...   \n",
       "9   \\n\\n      The primary outcome in this study is...   \n",
       "10  \\n\\n      Cancer which spreads to the brain (b...   \n",
       "11  \\n\\n      Bimatoprost 0.03% preservative free ...   \n",
       "12  \\n\\n      Sjogren-Larsson syndrome (SLS) is a ...   \n",
       "13  \\n\\n      To improve radiation therapy of pros...   \n",
       "14  \\n\\n      The purpose of this study is to comp...   \n",
       "15  \\n\\n      The purposes of this noninferiority ...   \n",
       "16  \\n\\n      Hypothesis: Continuation of an atypi...   \n",
       "17  \\n\\n      Patients undergoing major colorectal...   \n",
       "18  \\n\\n      Most Cystic fibrosis (CF) patients n...   \n",
       "19  \\n\\n      In the current study we will examine...   \n",
       "\n",
       "                                          brief_title          city  \\\n",
       "0   Cancer Symptom Monitoring Telephone System Wit...     Nashville   \n",
       "1      Stem Cell Therapy in Autism Spectrum Disorders        Mumbai   \n",
       "2   A Study in Cancer Patients to Evaluate the Eff...   Los Angeles   \n",
       "3   Using Ultrasound to Predict the Results of Dra...        Oxford   \n",
       "4   Widespread vs. Selective Screening for Hepatit...       Houston   \n",
       "5   High Tibial Osteotomy for Osteoarthritis of th...     Rotterdam   \n",
       "6   Effect of Olixia Pure速 Eye Drops on Tear Film ...        Vienna   \n",
       "7   Efficacy and Safety of Acetaminophen and Aspir...    Birmingham   \n",
       "8                Moxibustion for Primary Dysmenorrhea       Chengdu   \n",
       "9   Priority Setting and Waiting Time Decision in ...     Stavanger   \n",
       "10  Neurocognition After Gamma Knife Radiosurgery ...      Winnipeg   \n",
       "11  Intraocular Pressure and Tolerability Study of...        Vienna   \n",
       "12  Sjogren-Larsson Syndrome: Natural History, Cli...         Omaha   \n",
       "13  Functional MR-guided Stereotactic Body Radiati...      Winnipeg   \n",
       "14  Study of Picosecond and Nanosecond Q-switched ...      Brisbane   \n",
       "15      Narcotic vs. Non-narcotic Pain Study Protocol  Philadelphia   \n",
       "16  Atypical Antipsychotics for Continuation and M...     Vancouver   \n",
       "17  Prospective Study on Preoperative Versus Posto...   Los Angeles   \n",
       "18  Investigating the Incretin Effect in Cystic Fi...     Liverpool   \n",
       "19  The Effect of Physical Effort in the Decision ...     Jerusalem   \n",
       "\n",
       "                                       clinical_study  \\\n",
       "0   \\n\\n\\nClinicalTrials.gov processed this data o...   \n",
       "1   \\n\\n\\nClinicalTrials.gov processed this data o...   \n",
       "2   \\n\\n\\nClinicalTrials.gov processed this data o...   \n",
       "3   \\n\\n\\nClinicalTrials.gov processed this data o...   \n",
       "4   \\n\\n\\nClinicalTrials.gov processed this data o...   \n",
       "5   \\n\\n\\nClinicalTrials.gov processed this data o...   \n",
       "6   \\n\\n\\nClinicalTrials.gov processed this data o...   \n",
       "7   \\n\\n\\nClinicalTrials.gov processed this data o...   \n",
       "8   \\n\\n\\nClinicalTrials.gov processed this data o...   \n",
       "9   \\n\\n\\nClinicalTrials.gov processed this data o...   \n",
       "10  \\n\\n\\nClinicalTrials.gov processed this data o...   \n",
       "11  \\n\\n\\nClinicalTrials.gov processed this data o...   \n",
       "12  \\n\\n\\nClinicalTrials.gov processed this data o...   \n",
       "13  \\n\\n\\nClinicalTrials.gov processed this data o...   \n",
       "14  \\n\\n\\nClinicalTrials.gov processed this data o...   \n",
       "15  \\n\\n\\nClinicalTrials.gov processed this data o...   \n",
       "16  \\n\\n\\nClinicalTrials.gov processed this data o...   \n",
       "17  \\n\\n\\nClinicalTrials.gov processed this data o...   \n",
       "18  \\n\\n\\nClinicalTrials.gov processed this data o...   \n",
       "19  \\n\\n\\nClinicalTrials.gov processed this data o...   \n",
       "\n",
       "                                         collaborator completion_date  \\\n",
       "0            \\nNational Cancer Institute (NCI)\\nNIH\\n      April 2012   \n",
       "1                                                 NaN        May 2016   \n",
       "2                                                 NaN  September 2016   \n",
       "3                                                 NaN    May 16, 2017   \n",
       "4            \\nNational Cancer Institute (NCI)\\nNIH\\n   December 2019   \n",
       "5                                                 NaN      April 2004   \n",
       "6                                                 NaN   November 2013   \n",
       "7                                                 NaN       July 2014   \n",
       "8                                                 NaN       June 2014   \n",
       "9                                                 NaN       June 2014   \n",
       "10  \\nHealth Sciences Centre Foundation, Manitoba\\...  September 2015   \n",
       "11  \\nEuropean Vision Institute Clinical Research ...   February 2015   \n",
       "12                                                NaN     August 2019   \n",
       "13                                                NaN   December 2022   \n",
       "14                                                NaN             NaN   \n",
       "15        \\nLawson Health Research Institute\\nOther\\n      March 2019   \n",
       "16  \\nCanadian Institutes of Health Research (CIHR...     August 2011   \n",
       "17                                                NaN        May 2015   \n",
       "18                                                NaN       July 2015   \n",
       "19                                                NaN      April 2015   \n",
       "\n",
       "                         condition  \\\n",
       "0                           Cancer   \n",
       "1        Autism Spectrum Disorders   \n",
       "2                  Advanced Cancer   \n",
       "3                 Pleural Effusion   \n",
       "4                           Cancer   \n",
       "5                   Osteoarthritis   \n",
       "6                 Dry Eye Syndrome   \n",
       "7                   Acute Migraine   \n",
       "8             Primary Dysmenorrhea   \n",
       "9                    Communication   \n",
       "10             Neoplasm Metastases   \n",
       "11                        Glaucoma   \n",
       "12  Sjogren-Larsson Syndrome (SLS)   \n",
       "13             Prostatic Neoplasms   \n",
       "14                  Tattoo Removal   \n",
       "15                   Carpal Tunnel   \n",
       "16              Bipolar I Disorder   \n",
       "17          Venous Thromboembolism   \n",
       "18                 Cystic Fibrosis   \n",
       "19                            ADHD   \n",
       "\n",
       "                                     condition_browse         country  \\\n",
       "0                                                 NaN   United States   \n",
       "1   \\n\\nDisease\\nAutistic Disorder\\nAutism Spectru...           India   \n",
       "2                                                 NaN   United States   \n",
       "3                              \\n\\nPleural Effusion\\n  United Kingdom   \n",
       "4   \\n\\nInfection\\nHepatitis\\nHepatitis A\\nHepatit...   United States   \n",
       "5          \\n\\nOsteoarthritis\\nOsteoarthritis, Knee\\n     Netherlands   \n",
       "6   \\n\\nDry Eye Syndromes\\nKeratoconjunctivitis Si...         Austria   \n",
       "7                            \\n\\nMigraine Disorders\\n   United States   \n",
       "8                                  \\n\\nDysmenorrhea\\n           China   \n",
       "9                                                 NaN          Norway   \n",
       "10  \\n\\nNeoplasms\\nNeoplasm Metastasis\\nNeoplasms,...          Canada   \n",
       "11  \\n\\nHypertension\\nGlaucoma\\nOcular Hypertension\\n         Austria   \n",
       "12  \\n\\nSyndrome\\nSjogren's Syndrome\\nSjogren-Lars...   United States   \n",
       "13                          \\n\\nProstatic Neoplasms\\n          Canada   \n",
       "14                                                NaN   United States   \n",
       "15                       \\n\\nCarpal Tunnel Syndrome\\n   United States   \n",
       "16                                                NaN          Canada   \n",
       "17      \\n\\nThromboembolism\\nVenous Thromboembolism\\n   United States   \n",
       "18                    \\n\\nFibrosis\\nCystic Fibrosis\\n  United Kingdom   \n",
       "19                                                NaN          Israel   \n",
       "\n",
       "                                             criteria  \\\n",
       "0   \\n\\n        Inclusion Criteria:\\n\\n          -...   \n",
       "1   \\n\\n        Inclusion Criteria:\\n\\n          -...   \n",
       "2   \\n\\n        Inclusion Criteria:\\n\\n          -...   \n",
       "3   \\n\\n        Inclusion Criteria:\\n\\n          -...   \n",
       "4   \\n\\n        Inclusion Criteria:\\n\\n          1...   \n",
       "5   \\n\\n        Inclusion Criteria:\\n\\n          -...   \n",
       "6   \\n\\n        Inclusion Criteria:\\n\\n          -...   \n",
       "7   \\n\\n        Inclusion criteria:\\n\\n          1...   \n",
       "8   \\n\\n        Inclusion Criteria:\\n\\n          -...   \n",
       "9   \\n\\n        Inclusion Criteria:\\n\\n        All...   \n",
       "10  \\n\\n        Inclusion Criteria:\\n\\n          -...   \n",
       "11  \\n\\n        Inclusion Criteria includes:\\n\\n  ...   \n",
       "12  \\n\\n        Inclusion Criteria:\\n\\n          -...   \n",
       "13  \\n\\n        Inclusion Criteria:\\n\\n          -...   \n",
       "14  \\n\\n        Inclusion Criteria:\\n\\n          -...   \n",
       "15  \\n\\n        Inclusion Criteria:\\n\\n          -...   \n",
       "16  \\n\\n        Inclusion Criteria:\\n\\n          -...   \n",
       "17  \\n\\n        Inclusion Criteria:\\n\\n          1...   \n",
       "18  \\n\\n        Inclusion Criteria:\\n\\n          -...   \n",
       "19  \\n\\n        Inclusion Criteria:\\n\\n          -...   \n",
       "\n",
       "                                 detailed_description  \\\n",
       "0   \\n\\n      The purpose of this prospective tria...   \n",
       "1                                                 NaN   \n",
       "2   \\n\\n      This is an open-label study that wil...   \n",
       "3   \\n\\n      Study-specific interventions will be...   \n",
       "4   \\n\\n      Enrollment Visit:\\n\\n      If you ag...   \n",
       "5   \\n\\n      A prospective, randomised, controlle...   \n",
       "6                                                 NaN   \n",
       "7                                                 NaN   \n",
       "8   \\n\\n      There is no convincing evidence for ...   \n",
       "9   \\n\\n      Design:\\n\\n      A prospective clust...   \n",
       "10  \\n\\n      Patients with >=4 brain metastases w...   \n",
       "11                                                NaN   \n",
       "12  \\n\\n      The study will consist of a clinical...   \n",
       "13  \\n\\n      This project combines advances in fu...   \n",
       "14                                                NaN   \n",
       "15  \\n\\n      Participants will be provided with f...   \n",
       "16  \\n\\n      This is a randomised, double-blind, ...   \n",
       "17                                                NaN   \n",
       "18                                                NaN   \n",
       "19  \\n\\n      In the current study we will examine...   \n",
       "\n",
       "                                          eligibility  enrollment  \\\n",
       "0   \\n\\n\\n        Inclusion Criteria:\\n\\n         ...       358.0   \n",
       "1   \\n\\n\\n        Inclusion Criteria:\\n\\n         ...         0.0   \n",
       "2   \\n\\n\\n        Inclusion Criteria:\\n\\n         ...        33.0   \n",
       "3   \\n\\n\\n        Adults (> or = 18 years old) und...         2.0   \n",
       "4   \\n\\n\\n        Adult cancer patients scheduled ...      3441.0   \n",
       "5   \\n\\n\\n        Inclusion Criteria:\\n\\n         ...        92.0   \n",
       "6   \\n\\n\\n        Inclusion Criteria:\\n\\n         ...        16.0   \n",
       "7   \\n\\n\\n        Inclusion criteria:\\n\\n         ...       900.0   \n",
       "8   \\n\\n\\n        Inclusion Criteria:\\n\\n         ...       152.0   \n",
       "9   \\n\\n\\n        Inclusion Criteria:\\n\\n        A...        40.0   \n",
       "10  \\n\\n\\n        Patients with multiple (>= 4) br...         3.0   \n",
       "11  \\n\\n\\n        Inclusion Criteria includes:\\n\\n...        67.0   \n",
       "12  \\n\\n\\n        The study population will come f...        50.0   \n",
       "13  \\n\\n\\n        Inclusion Criteria:\\n\\n         ...        77.0   \n",
       "14  \\n\\n\\n        Inclusion Criteria:\\n\\n         ...        44.0   \n",
       "15  \\n\\n\\n        Inclusion Criteria:\\n\\n         ...       400.0   \n",
       "16  \\n\\n\\n        Inclusion Criteria:\\n\\n         ...       159.0   \n",
       "17  \\n\\n\\n        Inclusion Criteria:\\n\\n         ...       410.0   \n",
       "18  \\n\\n\\n        The CF Cohort will be recruited ...        50.0   \n",
       "19  \\n\\n\\n        residents of jerusalem\\n      \\n...        60.0   \n",
       "\n",
       "                                             facility  gender  \\\n",
       "0   \\nVanderbilt-Ingram Cancer Center\\n\\nNashville...     All   \n",
       "1   \\nNeurogen brain and spine institute\\n\\nMumbai...     All   \n",
       "2   \\nAmerican Institute of Research, Los Angeles\\...     All   \n",
       "3   \\nChurchill Hospital\\n\\nOxford\\nOX3 7LE\\nUnite...     All   \n",
       "4   \\nUniversity of Texas MD Anderson Cancer Cente...     All   \n",
       "5   \\nErasmus Medical Centre\\n\\nRotterdam\\n3015 CE...     All   \n",
       "6   \\nDepartment of Clinical Pharmacology\\n\\nVienn...     All   \n",
       "7          \\n\\nBirmingham\\nAlabama\\nUnited States\\n\\n     All   \n",
       "8   \\nAffiliated hospital of Chengdu University of...  Female   \n",
       "9   \\nStavanger University Hospital\\n\\nStavanger\\n...     All   \n",
       "10  \\nHealth Sciences Centre / CancerCare Manitoba...     All   \n",
       "11                            \\n\\nVienna\\nAustria\\n\\n     All   \n",
       "12  \\nUniversity of Nebraska Medical Center\\n\\nOma...     All   \n",
       "13  \\nCancerCare Manitoba\\n\\nWinnipeg\\nManitoba\\nR...    Male   \n",
       "14        \\n\\nBrisbane\\nCalifornia\\nUnited States\\n\\n     All   \n",
       "15  \\nThe Philadelphia Hand Center\\n\\nPhiladelphia...     All   \n",
       "16  \\nUniversity of British Columbia\\n\\nVancouver\\...     All   \n",
       "17  \\nCedars Sinai Medical Center\\n\\nLos Angeles\\n...     All   \n",
       "18  \\nLiverpool Heart and Chest Hospital\\n\\nLiverp...     All   \n",
       "19  \\nShaarei Zedek Medical Center\\n\\nJerusalem\\nI...     All   \n",
       "\n",
       "   has_expanded_access                                       intervention  \\\n",
       "0                   No  \\nOther\\nSymptom Alert and Coaching\\nPatients ...   \n",
       "1                   No  \\nProcedure\\nAutologous bone marrow mononuclea...   \n",
       "2                   No                       \\nDrug\\nNKTR-102\\nNKTR-102\\n   \n",
       "3                   No  \\nOther\\nPleural Manometry\\nIntrapleural press...   \n",
       "4                   No  \\nOther\\nHBV screening tests\\nThree (3) hepati...   \n",
       "5                   No  \\nProcedure\\nOpening-wedge HTO\\nOpening-wedge ...   \n",
       "6                   No  \\nDevice\\nOlixia pure eye drops\\nHealthy volun...   \n",
       "7                   No  \\nDrug\\nAcetaminophen 250 mg and Aspirin 250 m...   \n",
       "8                   No  \\nDevice\\nmoxibustion\\napply moxibustion accor...   \n",
       "9                   No  \\nBehavioral\\nPrioritization\\nteam-based multi...   \n",
       "10                  No  \\nRadiation\\nGamma knife radiosurgery\\nDependi...   \n",
       "11                  No  \\nDrug\\nPreservative-free latanoprost\\nLatanop...   \n",
       "12                  No                                                NaN   \n",
       "13                  No  \\nRadiation\\nStereotactic body RT with MR-guid...   \n",
       "14                  No  \\nDevice\\nPicosecond Q-switched Laser Treatmen...   \n",
       "15                  No  \\nDrug\\nNarcotic\\nHydrocodone 5mg + acetaminop...   \n",
       "16                  No  \\nDrug\\nValproate\\nserum level of 50 to 125 ug...   \n",
       "17                  No  \\nDrug\\nHeparin\\nSubcutaneous Heparin 5000 Uni...   \n",
       "18                  No  \\nDrug\\nOral Glucose Tolerance test (75g 2-hou...   \n",
       "19                  No                                                NaN   \n",
       "\n",
       "                                    intervention_name intervention_type  \\\n",
       "0                          Symptom Alert and Coaching             Other   \n",
       "1   Autologous bone marrow mononuclear cell transp...         Procedure   \n",
       "2                                            NKTR-102              Drug   \n",
       "3                                   Pleural Manometry             Other   \n",
       "4                                 HBV screening tests             Other   \n",
       "5                                   Opening-wedge HTO         Procedure   \n",
       "6                               Olixia pure eye drops            Device   \n",
       "7             Acetaminophen 250 mg and Aspirin 250 mg              Drug   \n",
       "8                                         moxibustion            Device   \n",
       "9                                      Prioritization        Behavioral   \n",
       "10                           Gamma knife radiosurgery         Radiation   \n",
       "11                      Preservative-free latanoprost              Drug   \n",
       "12                                                NaN               NaN   \n",
       "13          Stereotactic body RT with MR-guided boost         Radiation   \n",
       "14              Picosecond Q-switched Laser Treatment            Device   \n",
       "15                                           Narcotic              Drug   \n",
       "16                                          Valproate              Drug   \n",
       "17                                            Heparin              Drug   \n",
       "18           Oral Glucose Tolerance test (75g 2-hour)              Drug   \n",
       "19                                                NaN               NaN   \n",
       "\n",
       "                        keyword   last_known_status last_update_posted  \\\n",
       "0                        Cancer                 NaN      March 1, 2017   \n",
       "1     autism spectrum disorders                 NaN   October 25, 2018   \n",
       "2                           NaN                 NaN  December 22, 2016   \n",
       "3              Pleural Effusion                 NaN   January 10, 2018   \n",
       "4   hepatitis B virus infection                 NaN   January 15, 2019   \n",
       "5                           NaN                 NaN   November 6, 2013   \n",
       "6           tear film thickness                 NaN  November 27, 2013   \n",
       "7                      Migraine                 NaN      June 11, 2015   \n",
       "8                   moxibustion                 NaN   December 2, 2014   \n",
       "9       Comprehensive referrals  Not yet recruiting   November 5, 2013   \n",
       "10          Neoplasm metastasis                 NaN       May 30, 2016   \n",
       "11                     Glaucoma                 NaN   October 29, 2015   \n",
       "12                   ichthyosis                 NaN     March 11, 2019   \n",
       "13          Prostatic neoplasms                 NaN  February 20, 2019   \n",
       "14               Tattoo Removal                 NaN      July 28, 2014   \n",
       "15                  pain relief                 NaN  November 14, 2018   \n",
       "16                          NaN                 NaN  November 20, 2015   \n",
       "17                          NaN                 NaN   October 14, 2016   \n",
       "18                          NaN                 NaN  September 2, 2015   \n",
       "19                          NaN                 NaN  September 9, 2015   \n",
       "\n",
       "   last_update_submitted last_update_submitted_qc  \\\n",
       "0      February 28, 2017        February 28, 2017   \n",
       "1       October 23, 2018         October 23, 2018   \n",
       "2      December 20, 2016        December 20, 2016   \n",
       "3        January 8, 2018          January 8, 2018   \n",
       "4       January 11, 2019         January 11, 2019   \n",
       "5       October 30, 2013         October 30, 2013   \n",
       "6      November 26, 2013        November 26, 2013   \n",
       "7           June 9, 2015             June 9, 2015   \n",
       "8      November 25, 2014        November 25, 2014   \n",
       "9       October 29, 2013         October 29, 2013   \n",
       "10          May 27, 2016             May 27, 2016   \n",
       "11      October 28, 2015         October 28, 2015   \n",
       "12         March 8, 2019            March 8, 2019   \n",
       "13     February 19, 2019        February 19, 2019   \n",
       "14         July 24, 2014            July 24, 2014   \n",
       "15     November 11, 2018        November 11, 2018   \n",
       "16     November 19, 2015        November 19, 2015   \n",
       "17       August 21, 2016          August 21, 2016   \n",
       "18     September 1, 2015        September 1, 2015   \n",
       "19     September 6, 2015        September 6, 2015   \n",
       "\n",
       "                                         lead_sponsor  \\\n",
       "0                       \\nUniversity of Utah\\nOther\\n   \n",
       "1       \\nNeurogen Brain and Spine Institute\\nOther\\n   \n",
       "2                   \\nNektar Therapeutics\\nIndustry\\n   \n",
       "3                     \\nUniversity of Oxford\\nOther\\n   \n",
       "4              \\nM.D. Anderson Cancer Center\\nOther\\n   \n",
       "5                   \\nErasmus Medical Center\\nOther\\n   \n",
       "6             \\nMedical University of Vienna\\nOther\\n   \n",
       "7                              \\nNovartis\\nIndustry\\n   \n",
       "8   \\nChengdu University of Traditional Chinese Me...   \n",
       "9                     \\nUniversity of Bergen\\nOther\\n   \n",
       "10                     \\nCancerCare Manitoba\\nOther\\n   \n",
       "11  \\nAssociation for Innovation and Biomedical Re...   \n",
       "12                  \\nUniversity of Nebraska\\nOther\\n   \n",
       "13                     \\nCancerCare Manitoba\\nOther\\n   \n",
       "14                          \\nCutera Inc.\\nIndustry\\n   \n",
       "15                  \\nHorizon Health Network\\nOther\\n   \n",
       "16          \\nUniversity of British Columbia\\nOther\\n   \n",
       "17             \\nCedars-Sinai Medical Center\\nOther\\n   \n",
       "18  \\nLiverpool Heart and Chest Hospital NHS Found...   \n",
       "19             \\nShaare Zedek Medical Center\\nOther\\n   \n",
       "\n",
       "                                             location               mesh_term  \\\n",
       "0   \\n\\nVanderbilt-Ingram Cancer Center\\n\\nNashvil...                     NaN   \n",
       "1   \\n\\nNeurogen brain and spine institute\\n\\nMumb...                 Disease   \n",
       "2   \\n\\nAmerican Institute of Research, Los Angele...      Etirinotecan pegol   \n",
       "3   \\n\\nChurchill Hospital\\n\\nOxford\\nOX3 7LE\\nUni...        Pleural Effusion   \n",
       "4   \\n\\nUniversity of Texas MD Anderson Cancer Cen...               Infection   \n",
       "5   \\n\\nErasmus Medical Centre\\n\\nRotterdam\\n3015 ...          Osteoarthritis   \n",
       "6   \\n\\nDepartment of Clinical Pharmacology\\n\\nVie...       Dry Eye Syndromes   \n",
       "7      \\n\\n\\nBirmingham\\nAlabama\\nUnited States\\n\\n\\n      Migraine Disorders   \n",
       "8   \\n\\nAffiliated hospital of Chengdu University ...            Dysmenorrhea   \n",
       "9   \\n\\nStavanger University Hospital\\n\\nStavanger...                     NaN   \n",
       "10  \\n\\nHealth Sciences Centre / CancerCare Manito...               Neoplasms   \n",
       "11                        \\n\\n\\nVienna\\nAustria\\n\\n\\n            Hypertension   \n",
       "12  \\n\\nUniversity of Nebraska Medical Center\\n\\nO...                Syndrome   \n",
       "13  \\n\\nCancerCare Manitoba\\n\\nWinnipeg\\nManitoba\\...     Prostatic Neoplasms   \n",
       "14    \\n\\n\\nBrisbane\\nCalifornia\\nUnited States\\n\\n\\n                     NaN   \n",
       "15  \\n\\nThe Philadelphia Hand Center\\n\\nPhiladelph...  Carpal Tunnel Syndrome   \n",
       "16  \\n\\nUniversity of British Columbia\\n\\nVancouve...             Risperidone   \n",
       "17  \\n\\nCedars Sinai Medical Center\\n\\nLos Angeles...         Thromboembolism   \n",
       "18  \\n\\nLiverpool Heart and Chest Hospital\\n\\nLive...                Fibrosis   \n",
       "19  \\n\\nShaarei Zedek Medical Center\\n\\nJerusalem\\...                     NaN   \n",
       "\n",
       "                                       official_title  overall_status  \\\n",
       "0   Telephone Linked Care: An IT Enabled Integrate...       Completed   \n",
       "1   Open Label Study of Autologous Bone Marrow Mon...       Withdrawn   \n",
       "2   A Phase 1 Study to Evaluate the Effect of Nktr...       Completed   \n",
       "3   Correlation of Pleural Manometry With Real-tim...      Terminated   \n",
       "4   Widespread Versus Selective Screening for Hepa...      Recruiting   \n",
       "5   High Tibial Osteotomy for Osteoarthritis of th...       Completed   \n",
       "6   Effect of Olixia Pure速 Eye Drops on Tear Film ...       Completed   \n",
       "7   A Multi-center, Randomized, Double-blind, Para...       Completed   \n",
       "8   Traditional Chinese Moxibustion for Primary Dy...       Completed   \n",
       "9   Priority Setting and Waiting Time Decision in ...  Unknown status   \n",
       "10  Neurocognition After Gamma Knife Radiosurgery ...      Terminated   \n",
       "11  Intraocular Pressure and Tolerability Study of...       Completed   \n",
       "12  Sjogren-Larsson Syndrome: A Longitudinal Study...      Recruiting   \n",
       "13  Functional MR-guided Stereotactic Body Radiati...      Recruiting   \n",
       "14  Randomized, Split-tattoo Study Comparing Safet...       Completed   \n",
       "15  A Randomized, Controlled Trial Comparing Combi...      Recruiting   \n",
       "16  Atypical Antipsychotics for Continuation and M...       Completed   \n",
       "17  PROSPECTIVE STUDY ON PREOPERATIVE VERSUS POSTO...       Completed   \n",
       "18  Investigating the Incretin Effect in Cystic Fi...       Completed   \n",
       "19  The Effect of Physical Effort in the Decision ...       Completed   \n",
       "\n",
       "            phase primary_completion_date           primary_purpose  \\\n",
       "0             NaN              April 2012           Supportive Care   \n",
       "1         Phase 1            January 2016                 Treatment   \n",
       "2         Phase 1               June 2016                 Treatment   \n",
       "3             NaN            May 16, 2017                       NaN   \n",
       "4             NaN           December 2019                       NaN   \n",
       "5             NaN              April 2004                 Treatment   \n",
       "6         Phase 4           November 2013             Basic Science   \n",
       "7         Phase 3               July 2014                 Treatment   \n",
       "8   Early Phase 1           February 2014                 Treatment   \n",
       "9             NaN               June 2014  Health Services Research   \n",
       "10            NaN          September 2015                       NaN   \n",
       "11        Phase 4           February 2015                 Treatment   \n",
       "12            NaN             August 2019                       NaN   \n",
       "13            NaN           December 2020                 Treatment   \n",
       "14            NaN               July 2014                 Treatment   \n",
       "15        Phase 4              March 2019           Supportive Care   \n",
       "16        Phase 3             August 2011                 Treatment   \n",
       "17        Phase 3                May 2015                Prevention   \n",
       "18            NaN               July 2015                       NaN   \n",
       "19            NaN              April 2015                       NaN   \n",
       "\n",
       "                      role                                             source  \\\n",
       "0   Principal Investigator                                 University of Utah   \n",
       "1                      NaN                 Neurogen Brain and Spine Institute   \n",
       "2           Study Director                                Nektar Therapeutics   \n",
       "3              Study Chair                               University of Oxford   \n",
       "4              Study Chair                        M.D. Anderson Cancer Center   \n",
       "5                      NaN                             Erasmus Medical Center   \n",
       "6   Principal Investigator                       Medical University of Vienna   \n",
       "7           Study Director                                           Novartis   \n",
       "8   Principal Investigator  Chengdu University of Traditional Chinese Medi...   \n",
       "9              Study Chair                               University of Bergen   \n",
       "10  Principal Investigator                                CancerCare Manitoba   \n",
       "11  Principal Investigator  Association for Innovation and Biomedical Rese...   \n",
       "12             Study Chair                             University of Nebraska   \n",
       "13  Principal Investigator                                CancerCare Manitoba   \n",
       "14                     NaN                                        Cutera Inc.   \n",
       "15  Principal Investigator                             Horizon Health Network   \n",
       "16  Principal Investigator                     University of British Columbia   \n",
       "17  Principal Investigator                        Cedars-Sinai Medical Center   \n",
       "18  Principal Investigator  Liverpool Heart and Chest Hospital NHS Foundat...   \n",
       "19  Principal Investigator                        Shaare Zedek Medical Center   \n",
       "\n",
       "                                             sponsors        start_date  \\\n",
       "0   \\n\\nUniversity of Utah\\nOther\\n\\n\\nNational Ca...    September 2007   \n",
       "1   \\n\\nNeurogen Brain and Spine Institute\\nOther\\n\\n       August 2009   \n",
       "2               \\n\\nNektar Therapeutics\\nIndustry\\n\\n     February 2014   \n",
       "3                 \\n\\nUniversity of Oxford\\nOther\\n\\n    August 1, 2014   \n",
       "4   \\n\\nM.D. Anderson Cancer Center\\nOther\\n\\n\\nNa...         June 2013   \n",
       "5               \\n\\nErasmus Medical Center\\nOther\\n\\n      January 2001   \n",
       "6         \\n\\nMedical University of Vienna\\nOther\\n\\n      October 2013   \n",
       "7                          \\n\\nNovartis\\nIndustry\\n\\n      October 2013   \n",
       "8   \\n\\nChengdu University of Traditional Chinese ...     February 2012   \n",
       "9                 \\n\\nUniversity of Bergen\\nOther\\n\\n      January 2014   \n",
       "10  \\n\\nCancerCare Manitoba\\nOther\\n\\n\\nHealth Sci...        April 2014   \n",
       "11  \\n\\nAssociation for Innovation and Biomedical ...      October 2013   \n",
       "12              \\n\\nUniversity of Nebraska\\nOther\\n\\n        April 2013   \n",
       "13                 \\n\\nCancerCare Manitoba\\nOther\\n\\n  January 10, 2018   \n",
       "14                      \\n\\nCutera Inc.\\nIndustry\\n\\n    September 2013   \n",
       "15  \\n\\nHorizon Health Network\\nOther\\n\\n\\nLawson ...        March 2016   \n",
       "16  \\n\\nUniversity of British Columbia\\nOther\\n\\n\\...      January 2003   \n",
       "17         \\n\\nCedars-Sinai Medical Center\\nOther\\n\\n    September 2013   \n",
       "18  \\n\\nLiverpool Heart and Chest Hospital NHS Fou...     December 2013   \n",
       "19         \\n\\nShaare Zedek Medical Center\\nOther\\n\\n     November 2014   \n",
       "\n",
       "               state                                          textblock  \\\n",
       "0          Tennessee  \\n      The purpose of this prospective trial ...   \n",
       "1        Maharashtra  \\n      The purpose of this study was to study...   \n",
       "2         California  \\n      The purpose of this research study is ...   \n",
       "3                NaN  \\n      Pleural effusion is an extremely commo...   \n",
       "4              Texas  \\n      The goal of this clinical research stu...   \n",
       "5                NaN  \\n      A prospective, randomised, controlled ...   \n",
       "6                NaN  \\n      Dry eye syndrome (DES) is a common ocu...   \n",
       "7            Alabama  \\n      The purpose of the study is to evaluat...   \n",
       "8            Sichuan  \\n      Hypothesis: Moxibustion is effective f...   \n",
       "9                NaN  \\n      The primary outcome in this study is m...   \n",
       "10          Manitoba  \\n      Cancer which spreads to the brain (bra...   \n",
       "11               NaN  \\n      Bimatoprost 0.03% preservative free mo...   \n",
       "12          Nebraska  \\n      Sjogren-Larsson syndrome (SLS) is a ra...   \n",
       "13          Manitoba  \\n      To improve radiation therapy of prosta...   \n",
       "14        California  \\n      The purpose of this study is to compar...   \n",
       "15      Pennsylvania  \\n      The purposes of this noninferiority ra...   \n",
       "16  British Columbia  \\n      Hypothesis: Continuation of an atypica...   \n",
       "17        California  \\n      Patients undergoing major colorectal s...   \n",
       "18               NaN  \\n      Most Cystic fibrosis (CF) patients now...   \n",
       "19               NaN  \\n      In the current study we will examine a...   \n",
       "\n",
       "                                           time_frame time_perspective  \\\n",
       "0   Daily patient reports of symptom levels were m...              NaN   \n",
       "1                                          Six months              NaN   \n",
       "2                               Day -1 through Day 42              NaN   \n",
       "3                                      Up to 3 months      Prospective   \n",
       "4   Baseline blood tests, approximately 30 minutes...      Prospective   \n",
       "5                                            one year              NaN   \n",
       "6                                      up to one hour              NaN   \n",
       "7                                             2 hours              NaN   \n",
       "8   at baseline, 1st, 2nd, 3rd, 4th, 5th, 6th mens...              NaN   \n",
       "9                                              1 year              NaN   \n",
       "10                        4 months after radiosurgery      Prospective   \n",
       "11                                           6 months              NaN   \n",
       "12                               2017 (up to 5 years)      Prospective   \n",
       "13                                           6 months              NaN   \n",
       "14                12-weeks post-final laser treatment              NaN   \n",
       "15                                          7-15 days              NaN   \n",
       "16                                           52 weeks              NaN   \n",
       "17                              48 hour postop period              NaN   \n",
       "18                                            4 hours      Prospective   \n",
       "19                          immediately after testing  Cross-Sectional   \n",
       "\n",
       "                                            url  \n",
       "0   https://clinicaltrials.gov/show/NCT01973946  \n",
       "1   https://clinicaltrials.gov/show/NCT01974973  \n",
       "2   https://clinicaltrials.gov/show/NCT01976143  \n",
       "3   https://clinicaltrials.gov/show/NCT01973985  \n",
       "4   https://clinicaltrials.gov/show/NCT01970254  \n",
       "5   https://clinicaltrials.gov/show/NCT01977261  \n",
       "6   https://clinicaltrials.gov/show/NCT01970917  \n",
       "7   https://clinicaltrials.gov/show/NCT01973205  \n",
       "8   https://clinicaltrials.gov/show/NCT01972906  \n",
       "9   https://clinicaltrials.gov/show/NCT01976221  \n",
       "10  https://clinicaltrials.gov/show/NCT01970644  \n",
       "11  https://clinicaltrials.gov/show/NCT01975714  \n",
       "12  https://clinicaltrials.gov/show/NCT01971957  \n",
       "13  https://clinicaltrials.gov/show/NCT01976962  \n",
       "14  https://clinicaltrials.gov/show/NCT01973166  \n",
       "15  https://clinicaltrials.gov/show/NCT01974609  \n",
       "16  https://clinicaltrials.gov/show/NCT01977300  \n",
       "17  https://clinicaltrials.gov/show/NCT01976988  \n",
       "18  https://clinicaltrials.gov/show/NCT01975259  \n",
       "19  https://clinicaltrials.gov/show/NCT01978769  "
      ]
     },
     "execution_count": 19,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.head(20)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [],
   "source": [
    "df_new = df[[ 'brief_title', 'brief_summary', 'condition', 'intervention_name', 'phase', 'city', 'state', 'country', 'overall_status' ]]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>brief_title</th>\n",
       "      <th>brief_summary</th>\n",
       "      <th>condition</th>\n",
       "      <th>intervention_name</th>\n",
       "      <th>phase</th>\n",
       "      <th>city</th>\n",
       "      <th>state</th>\n",
       "      <th>country</th>\n",
       "      <th>overall_status</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Cancer Symptom Monitoring Telephone System Wit...</td>\n",
       "      <td>\\n\\n      The purpose of this prospective tria...</td>\n",
       "      <td>Cancer</td>\n",
       "      <td>Symptom Alert and Coaching</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Nashville</td>\n",
       "      <td>Tennessee</td>\n",
       "      <td>United States</td>\n",
       "      <td>Completed</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Stem Cell Therapy in Autism Spectrum Disorders</td>\n",
       "      <td>\\n\\n      The purpose of this study was to stu...</td>\n",
       "      <td>Autism Spectrum Disorders</td>\n",
       "      <td>Autologous bone marrow mononuclear cell transp...</td>\n",
       "      <td>Phase 1</td>\n",
       "      <td>Mumbai</td>\n",
       "      <td>Maharashtra</td>\n",
       "      <td>India</td>\n",
       "      <td>Withdrawn</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>A Study in Cancer Patients to Evaluate the Eff...</td>\n",
       "      <td>\\n\\n      The purpose of this research study i...</td>\n",
       "      <td>Advanced Cancer</td>\n",
       "      <td>NKTR-102</td>\n",
       "      <td>Phase 1</td>\n",
       "      <td>Los Angeles</td>\n",
       "      <td>California</td>\n",
       "      <td>United States</td>\n",
       "      <td>Completed</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Using Ultrasound to Predict the Results of Dra...</td>\n",
       "      <td>\\n\\n      Pleural effusion is an extremely com...</td>\n",
       "      <td>Pleural Effusion</td>\n",
       "      <td>Pleural Manometry</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Oxford</td>\n",
       "      <td>NaN</td>\n",
       "      <td>United Kingdom</td>\n",
       "      <td>Terminated</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Widespread vs. Selective Screening for Hepatit...</td>\n",
       "      <td>\\n\\n      The goal of this clinical research s...</td>\n",
       "      <td>Cancer</td>\n",
       "      <td>HBV screening tests</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Houston</td>\n",
       "      <td>Texas</td>\n",
       "      <td>United States</td>\n",
       "      <td>Recruiting</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                         brief_title  \\\n",
       "0  Cancer Symptom Monitoring Telephone System Wit...   \n",
       "1     Stem Cell Therapy in Autism Spectrum Disorders   \n",
       "2  A Study in Cancer Patients to Evaluate the Eff...   \n",
       "3  Using Ultrasound to Predict the Results of Dra...   \n",
       "4  Widespread vs. Selective Screening for Hepatit...   \n",
       "\n",
       "                                       brief_summary  \\\n",
       "0  \\n\\n      The purpose of this prospective tria...   \n",
       "1  \\n\\n      The purpose of this study was to stu...   \n",
       "2  \\n\\n      The purpose of this research study i...   \n",
       "3  \\n\\n      Pleural effusion is an extremely com...   \n",
       "4  \\n\\n      The goal of this clinical research s...   \n",
       "\n",
       "                   condition  \\\n",
       "0                     Cancer   \n",
       "1  Autism Spectrum Disorders   \n",
       "2            Advanced Cancer   \n",
       "3           Pleural Effusion   \n",
       "4                     Cancer   \n",
       "\n",
       "                                   intervention_name    phase         city  \\\n",
       "0                         Symptom Alert and Coaching      NaN    Nashville   \n",
       "1  Autologous bone marrow mononuclear cell transp...  Phase 1       Mumbai   \n",
       "2                                           NKTR-102  Phase 1  Los Angeles   \n",
       "3                                  Pleural Manometry      NaN       Oxford   \n",
       "4                                HBV screening tests      NaN      Houston   \n",
       "\n",
       "         state         country overall_status  \n",
       "0    Tennessee   United States      Completed  \n",
       "1  Maharashtra           India      Withdrawn  \n",
       "2   California   United States      Completed  \n",
       "3          NaN  United Kingdom     Terminated  \n",
       "4        Texas   United States     Recruiting  "
      ]
     },
     "execution_count": 21,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_new.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Completed                  1242\n",
       "Recruiting                  761\n",
       "Not yet recruiting          499\n",
       "Unknown status              156\n",
       "Active, not recruiting      110\n",
       "Terminated                  105\n",
       "Withdrawn                    48\n",
       "Enrolling by invitation      48\n",
       "Withheld                      8\n",
       "Suspended                     5\n",
       "Available                     1\n",
       "Name: overall_status, dtype: int64"
      ]
     },
     "execution_count": 22,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_new.overall_status.value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "metadata": {},
   "outputs": [],
   "source": [
    "df_mock = df_new.loc[df_new['overall_status'] == 'Recruiting']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>brief_title</th>\n",
       "      <th>brief_summary</th>\n",
       "      <th>condition</th>\n",
       "      <th>intervention_name</th>\n",
       "      <th>phase</th>\n",
       "      <th>city</th>\n",
       "      <th>state</th>\n",
       "      <th>country</th>\n",
       "      <th>overall_status</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Widespread vs. Selective Screening for Hepatit...</td>\n",
       "      <td>\\n\\n      The goal of this clinical research s...</td>\n",
       "      <td>Cancer</td>\n",
       "      <td>HBV screening tests</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Houston</td>\n",
       "      <td>Texas</td>\n",
       "      <td>United States</td>\n",
       "      <td>Recruiting</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>Sjogren-Larsson Syndrome: Natural History, Cli...</td>\n",
       "      <td>\\n\\n      Sjogren-Larsson syndrome (SLS) is a ...</td>\n",
       "      <td>Sjogren-Larsson Syndrome (SLS)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Omaha</td>\n",
       "      <td>Nebraska</td>\n",
       "      <td>United States</td>\n",
       "      <td>Recruiting</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>Functional MR-guided Stereotactic Body Radiati...</td>\n",
       "      <td>\\n\\n      To improve radiation therapy of pros...</td>\n",
       "      <td>Prostatic Neoplasms</td>\n",
       "      <td>Stereotactic body RT with MR-guided boost</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Winnipeg</td>\n",
       "      <td>Manitoba</td>\n",
       "      <td>Canada</td>\n",
       "      <td>Recruiting</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>Narcotic vs. Non-narcotic Pain Study Protocol</td>\n",
       "      <td>\\n\\n      The purposes of this noninferiority ...</td>\n",
       "      <td>Carpal Tunnel</td>\n",
       "      <td>Narcotic</td>\n",
       "      <td>Phase 4</td>\n",
       "      <td>Philadelphia</td>\n",
       "      <td>Pennsylvania</td>\n",
       "      <td>United States</td>\n",
       "      <td>Recruiting</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>32</th>\n",
       "      <td>In Situ Vaccine for Low-Grade Lymphoma: Combin...</td>\n",
       "      <td>\\n\\n      Our recent trials combining local ra...</td>\n",
       "      <td>Low-Grade B-cell Lymphoma</td>\n",
       "      <td>rhuFlt3L/CDX-301</td>\n",
       "      <td>Phase 1/Phase 2</td>\n",
       "      <td>New York</td>\n",
       "      <td>New York</td>\n",
       "      <td>United States</td>\n",
       "      <td>Recruiting</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                          brief_title  \\\n",
       "4   Widespread vs. Selective Screening for Hepatit...   \n",
       "12  Sjogren-Larsson Syndrome: Natural History, Cli...   \n",
       "13  Functional MR-guided Stereotactic Body Radiati...   \n",
       "15      Narcotic vs. Non-narcotic Pain Study Protocol   \n",
       "32  In Situ Vaccine for Low-Grade Lymphoma: Combin...   \n",
       "\n",
       "                                        brief_summary  \\\n",
       "4   \\n\\n      The goal of this clinical research s...   \n",
       "12  \\n\\n      Sjogren-Larsson syndrome (SLS) is a ...   \n",
       "13  \\n\\n      To improve radiation therapy of pros...   \n",
       "15  \\n\\n      The purposes of this noninferiority ...   \n",
       "32  \\n\\n      Our recent trials combining local ra...   \n",
       "\n",
       "                         condition                          intervention_name  \\\n",
       "4                           Cancer                        HBV screening tests   \n",
       "12  Sjogren-Larsson Syndrome (SLS)                                        NaN   \n",
       "13             Prostatic Neoplasms  Stereotactic body RT with MR-guided boost   \n",
       "15                   Carpal Tunnel                                   Narcotic   \n",
       "32       Low-Grade B-cell Lymphoma                           rhuFlt3L/CDX-301   \n",
       "\n",
       "              phase          city         state        country overall_status  \n",
       "4               NaN       Houston         Texas  United States     Recruiting  \n",
       "12              NaN         Omaha      Nebraska  United States     Recruiting  \n",
       "13              NaN      Winnipeg      Manitoba         Canada     Recruiting  \n",
       "15          Phase 4  Philadelphia  Pennsylvania  United States     Recruiting  \n",
       "32  Phase 1/Phase 2      New York      New York  United States     Recruiting  "
      ]
     },
     "execution_count": 26,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_mock.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "metadata": {},
   "outputs": [],
   "source": [
    "df_mock = df_mock.drop('overall_status', axis=1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "metadata": {},
   "outputs": [],
   "source": [
    "df_mock = df_mock.head(10)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>brief_title</th>\n",
       "      <th>brief_summary</th>\n",
       "      <th>condition</th>\n",
       "      <th>intervention_name</th>\n",
       "      <th>phase</th>\n",
       "      <th>city</th>\n",
       "      <th>state</th>\n",
       "      <th>country</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Widespread vs. Selective Screening for Hepatit...</td>\n",
       "      <td>\\n\\n      The goal of this clinical research s...</td>\n",
       "      <td>Cancer</td>\n",
       "      <td>HBV screening tests</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Houston</td>\n",
       "      <td>Texas</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>Sjogren-Larsson Syndrome: Natural History, Cli...</td>\n",
       "      <td>\\n\\n      Sjogren-Larsson syndrome (SLS) is a ...</td>\n",
       "      <td>Sjogren-Larsson Syndrome (SLS)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Omaha</td>\n",
       "      <td>Nebraska</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>Functional MR-guided Stereotactic Body Radiati...</td>\n",
       "      <td>\\n\\n      To improve radiation therapy of pros...</td>\n",
       "      <td>Prostatic Neoplasms</td>\n",
       "      <td>Stereotactic body RT with MR-guided boost</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Winnipeg</td>\n",
       "      <td>Manitoba</td>\n",
       "      <td>Canada</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>Narcotic vs. Non-narcotic Pain Study Protocol</td>\n",
       "      <td>\\n\\n      The purposes of this noninferiority ...</td>\n",
       "      <td>Carpal Tunnel</td>\n",
       "      <td>Narcotic</td>\n",
       "      <td>Phase 4</td>\n",
       "      <td>Philadelphia</td>\n",
       "      <td>Pennsylvania</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>32</th>\n",
       "      <td>In Situ Vaccine for Low-Grade Lymphoma: Combin...</td>\n",
       "      <td>\\n\\n      Our recent trials combining local ra...</td>\n",
       "      <td>Low-Grade B-cell Lymphoma</td>\n",
       "      <td>rhuFlt3L/CDX-301</td>\n",
       "      <td>Phase 1/Phase 2</td>\n",
       "      <td>New York</td>\n",
       "      <td>New York</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>34</th>\n",
       "      <td>HIV-related Accelerated Aging of the Airway Ep...</td>\n",
       "      <td>\\n\\n      In cigarette smokers that are HIV+, ...</td>\n",
       "      <td>HIV</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>New York</td>\n",
       "      <td>New York</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>45</th>\n",
       "      <td>Predictive Clinical and Biological Parameters ...</td>\n",
       "      <td>\\n\\n      Research of predictive clinical and ...</td>\n",
       "      <td>Ovarian Cancer</td>\n",
       "      <td>gynecological cancer</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Marseille</td>\n",
       "      <td>NaN</td>\n",
       "      <td>France</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>70</th>\n",
       "      <td>Assessment of Early Treatment Response by Diff...</td>\n",
       "      <td>\\n\\n      Magnetic resonance imaging (MRI) is ...</td>\n",
       "      <td>Brain Cancer</td>\n",
       "      <td>MRI</td>\n",
       "      <td>NaN</td>\n",
       "      <td>New York</td>\n",
       "      <td>New York</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>80</th>\n",
       "      <td>Cancer and Anesthesia: Survival After Radical ...</td>\n",
       "      <td>\\n\\n      The purpose of this study is to dete...</td>\n",
       "      <td>Breast Neoplasms</td>\n",
       "      <td>Propofol</td>\n",
       "      <td>Phase 4</td>\n",
       "      <td>Beijing</td>\n",
       "      <td>NaN</td>\n",
       "      <td>China</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>85</th>\n",
       "      <td>Phase 1b Study of PD-0332991 in Combination Wi...</td>\n",
       "      <td>\\n\\n      Standard of care:\\n\\n      Treatment...</td>\n",
       "      <td>Advanced Breast Cancer</td>\n",
       "      <td>PD-0332991 and T-DM1</td>\n",
       "      <td>Phase 1</td>\n",
       "      <td>Dallas</td>\n",
       "      <td>Texas</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                          brief_title  \\\n",
       "4   Widespread vs. Selective Screening for Hepatit...   \n",
       "12  Sjogren-Larsson Syndrome: Natural History, Cli...   \n",
       "13  Functional MR-guided Stereotactic Body Radiati...   \n",
       "15      Narcotic vs. Non-narcotic Pain Study Protocol   \n",
       "32  In Situ Vaccine for Low-Grade Lymphoma: Combin...   \n",
       "34  HIV-related Accelerated Aging of the Airway Ep...   \n",
       "45  Predictive Clinical and Biological Parameters ...   \n",
       "70  Assessment of Early Treatment Response by Diff...   \n",
       "80  Cancer and Anesthesia: Survival After Radical ...   \n",
       "85  Phase 1b Study of PD-0332991 in Combination Wi...   \n",
       "\n",
       "                                        brief_summary  \\\n",
       "4   \\n\\n      The goal of this clinical research s...   \n",
       "12  \\n\\n      Sjogren-Larsson syndrome (SLS) is a ...   \n",
       "13  \\n\\n      To improve radiation therapy of pros...   \n",
       "15  \\n\\n      The purposes of this noninferiority ...   \n",
       "32  \\n\\n      Our recent trials combining local ra...   \n",
       "34  \\n\\n      In cigarette smokers that are HIV+, ...   \n",
       "45  \\n\\n      Research of predictive clinical and ...   \n",
       "70  \\n\\n      Magnetic resonance imaging (MRI) is ...   \n",
       "80  \\n\\n      The purpose of this study is to dete...   \n",
       "85  \\n\\n      Standard of care:\\n\\n      Treatment...   \n",
       "\n",
       "                         condition                          intervention_name  \\\n",
       "4                           Cancer                        HBV screening tests   \n",
       "12  Sjogren-Larsson Syndrome (SLS)                                        NaN   \n",
       "13             Prostatic Neoplasms  Stereotactic body RT with MR-guided boost   \n",
       "15                   Carpal Tunnel                                   Narcotic   \n",
       "32       Low-Grade B-cell Lymphoma                           rhuFlt3L/CDX-301   \n",
       "34                             HIV                                        NaN   \n",
       "45                  Ovarian Cancer                       gynecological cancer   \n",
       "70                    Brain Cancer                                        MRI   \n",
       "80                Breast Neoplasms                                   Propofol   \n",
       "85          Advanced Breast Cancer                       PD-0332991 and T-DM1   \n",
       "\n",
       "              phase          city         state        country  \n",
       "4               NaN       Houston         Texas  United States  \n",
       "12              NaN         Omaha      Nebraska  United States  \n",
       "13              NaN      Winnipeg      Manitoba         Canada  \n",
       "15          Phase 4  Philadelphia  Pennsylvania  United States  \n",
       "32  Phase 1/Phase 2      New York      New York  United States  \n",
       "34              NaN      New York      New York  United States  \n",
       "45              NaN     Marseille           NaN         France  \n",
       "70              NaN      New York      New York  United States  \n",
       "80          Phase 4       Beijing           NaN          China  \n",
       "85          Phase 1        Dallas         Texas  United States  "
      ]
     },
     "execution_count": 30,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_mock"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "metadata": {},
   "outputs": [],
   "source": [
    "df_mock.to_csv('mock_sample.csv')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 50,
   "metadata": {},
   "outputs": [],
   "source": [
    "df_mock.to_json('mock_sample.JSON')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "metadata": {},
   "outputs": [],
   "source": [
    "import json"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "metadata": {},
   "outputs": [
    {
     "ename": "TypeError",
     "evalue": "dump() missing 1 required positional argument: 'fp'",
     "output_type": "error",
     "traceback": [
      "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[0;31mTypeError\u001b[0m                                 Traceback (most recent call last)",
      "\u001b[0;32m<ipython-input-39-3fe438ddee5f>\u001b[0m in \u001b[0;36m<module>\u001b[0;34m\u001b[0m\n\u001b[1;32m      1\u001b[0m \u001b[0;32mwith\u001b[0m \u001b[0mopen\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m'mock_sample.JSON'\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0;34m'rb'\u001b[0m\u001b[0;34m)\u001b[0m \u001b[0;32mas\u001b[0m \u001b[0mf2\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m----> 2\u001b[0;31m   \u001b[0mjs\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mjson\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mdump\u001b[0m\u001b[0;34m(\u001b[0m \u001b[0mf2\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m",
      "\u001b[0;31mTypeError\u001b[0m: dump() missing 1 required positional argument: 'fp'"
     ]
    }
   ],
   "source": [
    "with open('mock_sample.JSON', 'rb') as f2:\n",
    "  js = json.dump( f2)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "/Users/connorheraty/Desktop/Repos/Build-Week/clinical_trial/eb-flask\n"
     ]
    }
   ],
   "source": [
    "cd eb-flask"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "metadata": {},
   "outputs": [],
   "source": [
    "data = {}"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 45,
   "metadata": {},
   "outputs": [],
   "source": [
    "with open('mock_sample.JSON', 'w') as f2:\n",
    "    js = json.dump(data, f2)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 49,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<_io.TextIOWrapper name='mock_sample.JSON' mode='w' encoding='UTF-8'>"
      ]
     },
     "execution_count": 49,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "f2"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.1"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
